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The role of major naurotransmitter pathways is epilepsy  
Epilepsy is one of the most common neurological disorders, affecting about 1% of 
human population worldwide. Epilepsy is characterized by the repeated occurrence of 
sudden, transitory and localized bursts of electrical activity, known as seizures. Seizures 
are temporary alterations in brain functions due to abnormal electrical activity of a 
group of brain cells that result in a wide variety of clinical and sub-clinical symptoms. 
 
A large body of experimental evidence suggests that overactivity of the excitatory 
neurotransmitter glutamate, or reduced activity of the inhibitory neurotransmitter 
GABA, is central to the process of epileptogenesis. However, all major neurotransmitter 
pathways regulate overall brain excitability and are involved in epileptogenesis. 
Specifically, monoamines represent a group of neuroactive substances that are capable 
of regulating the initiation  and spread of  seizure  activity. Dopamine (DA) may be 
crucially involved in propagation of seizure and control of seizure threshold (Starr 
1996). Serotonin (5-hydroxytryptamine, 5-HT) is another monoaminergic transmitter 
crucially involed in seizure propoagation. Different types of 5-HT receptors are present 
on the cortical and/or hippocampal glutamatergic or GABAergic neurons or terminals, 
where they can cause a significant shift in excitability in most networks involved in 
epilepsy (Badgy et al. 2007). Classical pharmacological studies clearly showed that 
both DA and 5-HT may have potent anti-convulsant effects, acting through specific 
receptor pathways.  
 
There is a substantial body of clinical data in support of an antiepileptic action of 
dopamine in man. It is widely accepted that agents which increase dopamine level 
(dopamine agonists) are considered as an anticonvulsants and reduce the seizure 
threshold, while agents which block dopamine action (dopamine antagonists) are 
considered as a proconvulsants. Consistent with that, clinical data not only indicate that 
high dopaminergic activity in the brain suppresses seizure activity, but also that a 
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reduction of dopaminergic tone is pro-epileptogenic (Starr, 1996). This led to 
hypothesize that  dopamine  is  an  important  suppressor of  the processes which govern  
the genesis and propagation of  seizures. 
 
Studies in animal models and analysis of dissected tissue from epileptic patients provide 
evidence that endogenous 5-HT, the activity of its receptors, and pharmaceuticals with 
serotonin agonist and/or antagonist properties play a significant role in the pathogenesis 
of epilepsies (Bagdy et al. 2007). The effects of genetic manipulation and 
pharmacological intervention (including the effects of subtype-selective receptor 
agonists and antagonists) on the development of seizure and epileptic activity have been 
clearly characterized (see below). Moreover, anti-epileptic drugs elevate and/or 
stimulate basal 5-HT levels and/or release, (Okada et al. 1992; Dailey et al. 1996; 
Ahmad et al. 2005). 
 
Dopamine synthesis and Dopaminergic transmission 
Dopaminergic pathways are neural pathways in the brain by which dopamine is spread 
to a range of different destinations in the brain. There are four major central dopamine-
containing pathways, which are described in Figure 1. 
 
1) The nigrostriatal pathway, in which substantia nigra (SN) neurons innervate the     
           striatum. This pathway is involved in movement control. 
2) The mesocortical pathway, which links the ventral tegmental area (VTA) to medial   
prefrontal, cingulate and entorhinal cortices. This pathway is involved in 
motivational and emotional responses. 
3)  The mesolimbic pathway, composed of VTA cells projecting to the nucleus 
accumbens and other limbic areas which includes the amygdala and the 
hippocampus. This pathway is significantly involved with reward and pleasure 
response. 
4) The tuberoinfundibular system, which projects from arcuate and periventricular 
nuclei of the hypothalamus to the pituitary gland and is involved in the control of 







Figure 1. Schematic representation of major dopaminergic pathways in rodents, originate from groups of 
cells in the rostral areas of the brain (Kandel, Principles of Neural Science, 4th edition)   
 
All these pathways are involved in several neurological, psychiatric and neuroendocrine 
diseases (Figure 2). Reduced dopamine levels in the nigrostriatal pathway, resulting 
from selective loss of SN cells, are the primary cause of Parkinson’s disease. Reduced 
function of the nigrostriatal system (as a consequence of striatal degeneration) is also 
typical of Huntington’s disease. Conversely, increased dopamine signalling in the 
striatum and frontal lobes has been implicated in attention-deficit–hyperactivity disorder 
(ADHD; Madras et al. 2005). Increased levels of dopamine in the mesolimbic pathway, 
namely in the nucleus accumbens, represent the neurobiological substrate of the 
rewarding properties of all drugs of abuse, and also contribute to appetite disorders 
(Volkow and Wise 2005). 
 
Altered dopamine signalling in the limbic system has also been implicated in epilepsy 
(Starr, 1996; Bozzi et al. 2000) and, more recently, in depression (Park et al. 2005). 
Finally, reduced dopamine signalling to the hypophysis is clearly implicated in the 






Figure 2. Alterations of dopamine systems in neurological, neuroendocrine and psychiatric diseases. 
Dopamine pathways are shown in different colours (red, nigrostriatal; blue, mesocortical and mesolimbic; 
orange, tuberoinfundibular). Altered levels of dopamine function in specific areas are indicated for the 
different pathologies. Abbreviations: ADHD, attention-deficit–hyperactivity disorder; HT, hypothalamus; 
nAcb, nucleus accumbens; SN, substantia nigra; VTA, ventral tegmental area (from Bozzi and Borrelli, 
2006). 
 
                  Dopamine synthesis, like that of all catecholamines, originates from the 
amino acid precursor tyrosine, which must be transported across the blood brain barrier 
into the dopamine neuron. Dopamine is synthesized in the body (mainly by nervous 
tissue and the medulla of the adrenal glands) first by the hydroxylation of the amino 
acid L-tyrosine to L-DOPA via the enzyme tyrosine 3-monooxygenase, also known as 
tyrosine hydroxylase, and then by the decarboxylation of L-DOPA by aromatic L-amino 
acid decarboxylase (which is often referred to as dopa decarboxylase).  This latter 
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enzyme turns over so rapidly that DOPA levels in the brain are negligible under normal 
condition. Because of the high activity of this enzyme and the low endogenous levels of 
DOPA normally present in the brain, it is impossible to enhance dramatically the 
formation of dopamine by providing this enzyme with increased amount of substrate. 
Since tyrosine hydroxylase is the rate-limiting enzyme in the biosynthesis of dopamine, 
this enzyme sets the pace for the formation of dopamine synthesis and physiological 
regulation (Figure 3). 
 
Figure 3. Biosynthesis of Dopamine- Tyrosine, an amino acid abundant in dietary proteins, is first 
hydroxylated into L-DOPA.  The cytostolic enzyme, tyrosine hyroxylase, catalyses this conversion and is 
normally the rate-limiting step in dopamine biosynthesis.  Subsequently, aromatic amino acid 
decarboxylase (dopa-carboxylase) catalyses the conversion of L-DOPA to dopamine 
(http://sprojects.mmi.mcgill.ca/gait/parkinson/biochemistry.asp) 
 
              In dopaminergic neurons, dopamine is transported from the cytoplasm to 
specialized storage vesicles. Upon the arrival of an action potential which triggers 
subsequent exocytosis, vesicles discharge the neurostransmitters into the synapse. 
Dopaminergic terminals possess transporters (dopamine transporter, DAT) that are 
critical in terminating transmitter action and in maintaining transmitter homeostatsis 
through DA reuptake (figure 4). Under normal conditions, potent, high-affinity 
membrane carriers recycle dopamine that has been released into synaptic cleft by 





The dopamine receptor family contains five members that, according to structural and 
pharmacological similarities, are divided into two sub- families: the D1-like family, 
comprising D1 and D5 receptors; and the D2-like family, which includes D2, D3 and 
D4 receptors (Cooper 1996; Jackson et al. 1994).  
 
 
Figure 4. Schematic drawing of dopaminergic neurotransmission- The key steps in synthesis and 
degradation of dopamine (http://www.nibb.ac.jp/en/sections/sasaoka.html). 
 
 
DA and epilepsy.  
DA has long been postulated to have an anti-epileptic action. The anti-convulsant 
properties of apomorphine (a prototypic DA agonist) were first described more than one 
century ago. Seizure inhibition has been also observed in patients administered 
amphetamines or antiparkinsonian drugs such as pergolide and bromocriptine, which 
are potent D2 agonists, which all stimulate dopaminergic transmission. For example 
Gatterau and coworkers (1990) found that pergolide  gave  complete  relief  against  
temporal  lobe  epilepsy when administered  to patients in a daily dose  of  25-50  pg  
for  8 months. Moreover, the protection lasted for a further 27 months after 
discontinuing the treatment. Mauro et al. (1986) gave bromocriptine in conjunction with 
 12
 
the MAO-B (Monoamine Oxidase-B) inhibitor selegiline to patients  suffering  from  
Lafora’s disease  and  showed  it markedly reduced the frequency of generalised 
convulsive seizures and myoclonic  jerks. 
 
There are several reports dealing with the influence of 6-OHDA (6- hydroxydopamine) 
treatment on seizure sensitivity during early postnatal development. London and 
Buterbaugh (1978) showed that intracisternal 6-OHDA modified tonic pentylenetetrazol 
convulsions in young rats. Also, MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) 
selectively depleted brain dopamine (but not noradrenaline or 5-hydroxytryptamine) 
and abolished strychnine and electroshock-induced seizures in mice (Fariello et al.  
1987). 
 
The use of dopaminergic ligands specific for the different subclasses of DA receptors 
allowed to demonstrate that DA has an anti-epileptic action also in a wide variety of 
animal models (Starr 1993, 1996). In particular, these studies illustrated the opposite 
actions of D1-like and D2-like receptors in the regulation of seizure activity. The 
physiological balance of DA activity at these two different receptors would be crucial 
for determining the response to seizure-promoting stimuli: activation of D1-like 
receptors is generally pro-convulsant, whereas D2-like receptor stimulation can block 
seizures. More recently, studies performed on different dopamine receptor knockout 
mouse lines confirmed these findings (Bozzi et al. 2006; Bozzi et al. 2002; Bozzi et al. 
2000; O'Sullivan et al. 2008). The limbic system is crucially involved in the 
dopaminergic control of epileptic seizures. Indeed, limbic areas of the brain receive 
dopaminergic innervation (Verney et al. 1985) and express different types of DA 
receptors (Jackson et al. 1994).  Indeed, a high abundance of DA D1 and D2 receptors 
has also been detected in amygdala (Camps  et  al.  1990, Palacios and  Pazos,  1987). 
DA D2  receptor  levels  are medium  to high  in  laminae V  and VI  in both cingulate 
and  temporal cortex and  in  the  entorhinal  cortex  (Bouthenet  et  al. 1987), while 
mRNA for the DA D5 receptor has been detected mainly in hippocampal (Meador-




5-HT synthesis and 5-HT transmission 
The principal centres for serotonergic neurons are the rostral and caudal raphe nuclei. 
From the rostral raphe nuclei axons ascend to the cerebral cortex, limbic regions and 
specifically to the basal ganglia. Serotonergic nuclei in the brain stem give rise to 
descending axons, some of which terminate in the medulla, while others descend the 
spinal cord (Figure 5). Serotonin plays a role in many brain processes, including 
regulation of body temperature, sleep, mood, appetite and pain. Problems with the 
serotonin pathway can cause obsessive-compulsive disorder, anxiety disorders, and 
depression. 
 
Figure 5.  The major human (A) and rodents (B) serotonergic pathways arise in the raphe nuclei 
(Adapted from Heimer 1995 and Kandel, Principles of Neural Science, 4th edition).  
 
Serotonin is synthesized from the amino acid L-tryptophan (Figure 6). Transformation 
of tryptophan into serotonin involves two steps:  
      1) Hydroxylation in 5-hydroxytryptophan catalyzed by tryptophan hydroxylase  
    (TPH). 
2) Decarboxylation of 5-hydroxytryptophan is catalyzed by L-aromatic amino acid    
    decarboxylase (DDC). 
 
TPH-mediated reaction is the rate-limiting step in the pathway. TPH has been shown to 
exist in two forms: TPH1, found in several tissues, and TPH2, which is a brain-specific 






Figure 6.  Serotonin is synthesized from the amino acid L-tryptophan by a short metabolic pathway 









which crosses the blood-brain barrier. Only free plasma tryptophan penetrates into the 
brain.  
 
5-HT receptors are a group of G protein-coupled receptors (GPCRs) and ligand-gated 
ion channels (LGICs) found in the central and peripheral nervous system.There are 7 
different types of 5-HT receptors (5-HT1 to 5-HT7) and each of 7 classes contains 
many receptor subtypes. 
 
Serotonergic action is terminated primarily via uptake of 5-HT from the synapse. This is 
through the specific monoamine serotonin transporter (SERT), on the presynaptic 
neuron. Various agents can inhibit 5-HT reuptake including tricyclic antidepressants 
(TCAs) and selective serotonin reuptake inhibitors (SSRIs) (Figure 7). 
 
 
5-HT and epilepsy 
The idea that there may be a link between 5-HT and seizure inhibition was first 
suggested as early as 1957 (Bonnycastle et al.). In this study, a series of 
anticonvulsants, including phenytoin, were shown to elevate brain 5-HT levels. In 
recent years, there has been increasing evidence that serotonergic neurotransmission can 
modulate seizures in a wide variety of experimental models. It is now generally 
accepted that drugs elevating extracellular 5-HT levels (such as 5-hydroxytryptophan or 
selective serotonin reuptake inhibitors, SSRI) exert a powerful antiepileptic action 
against both focal (limbic) and generalized seizures (Löscher 1984; Prendiville et al. 
1993; Yan et al. 1994). The anticonvulsant effect of the SSRI fluoxetine has been 
clearly demonstrated in a wide variety of experimentally-induced seizure models, as 
well as in genetically epileptic animals. Conversely, depletion of brain 5-HT by para-
chloroamphetamine (PCA, a selective neurotoxin for 5-HT neurons) or para-
chlorophenilalanine (pCPA, an inhibitor of 5-HT synthesis) can lower seizure threshold, 





5-HT receptors are expressed in almost all networks involved in epilepsies. Audiogenic 
seizures are the best known defect caused by genetic manipulation of a 5-HT receptor 
subtype which provides a robust model for examination of the serotonergic mechanism 
in epilepsy. Mutant mice lacking the 5-HT2C receptor subtype are extremely 
susceptible to audiogenic seizures and are prone to spontaneous death after seizures, 
suggesting that serotonergic neurotransmission mediated by 5-HT2C receptors 
suppresses neuronal network hyperexcitability and in turn seizure activity (Tecott et al. 
1995; Brennan et al. 1997; Applegate and Tecott 1998). 5-HT1A receptor knockout 
mice display lower seizure threshold and higher lethality in response to glutamate 
agonist kainic acid (KA) administration. Furthermore, 5-HT1A knockout mice 
demonstrate impaired hippocampal-dependent learning and enhanced anxiety related 
behaviours (Sarnyai et al. 2000; Parsons et al. 2001). The areas which are crucially 
involved in the serotonergic control of seizures are the ventral midbrain and limbic 
system such as amygdala and hippocampus.  
 
Fourteen mammalian 5-HT receptor subtypes are currently recognized, and these have 
been classified into seven receptor families on the basis of their structural, functional 
and, to some extent, pharmacological characteristics (Bradley et al. 1986; Hoyer et al. 
1994). Among these receptors, the 5-HT1A, 5-HT2C, 5-HT3 and 5-HT7 subtypes, 
which are all expressed in epileptogenic brain areas (mainly, cerebral cortex and/or 
hippocampus), are the most relevant in epilepsy (Bagdy et al. 2007). 5-HT1A receptors 
are located both postsynaptically to 5-HT neurons (in the forebrain regions) at the level 
of the soma and dentrites in the mesencephalic and medullary raphe nuclei, cortical 
pyramidal neurons as well as pyramidal and granular neurons of the hippocampus 
(Francis et al. 1992). 5-HT2C binding sites are widely distributed and present in 
choroid plexus, areas of the cortex (olfactory nucleus, pyriform, cingulated and 
retrospenial), limbic system (nucleus accumbens, hippocampus and amygdala) and the 
basal ganglia (caudate nucleus and substantia nigra). 5-HT3 receptors are found in the 
nervous system both centrally and peripherally. The highest density of 5-HT3 receptors 
in the brain is found in the nuclei of the brainstem. Lower densities of 5-HT3-binding 
sites are found in the cortex and areas of limbic region such as hippocampus, amygdala, 
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and in medial nucleus of the habenula. 5-HT7 receptor expression is relatively high 
within the thalamus, hypothalamus and hippocampus with generally lower levels in 
areas such as the cerebral cortex and amygdala (To et al. 1995; Gustafson et al. 1996; 
Stowe and Barnes 1998). 
 
Indeed, the role of at least 5-HT1A, 5-HT2C, 5-HT3 and 5-HT7 receptor subtypes in 
epileptogenesis and/or seizure propagation has been described. These receptors are 
present on cortical and/or hippocampal glutamatergic or GABAergic neurons or 
terminals (Bagdy et al. 2007). For example, 5-HT1A receptor knockout mice display 
lower seizure thresholds and higher lethality in response to kainic acid administration 
(Sarnyai et al. 2000). Growing body of evidence suggest that 5-HT1A receptors may 
have an inhibitory role in the generation of hippocampal seizures and it depends on 5-
HT1A postsynaptic receptors. Neuroanatomical evidence shows a dense innervation of 
5-HT fibres to the hippocampus mainly originating from the median raphe forebrain 
nucleus (Azmitia & Segal, 1978).  
 
Inhibition of epileptiform bursts was also achieved with the selective 5-HT1A agonist, 
8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT, a specific 5-HT1A agonist). 
They found that these effects were completely antagonized by WAY-100135, a 5-HT1A 
receptor antagonist (Salgado and Alkadhi, 1995). Administration of 8-OH-DPAT is able 
to reduce experimentally induced seizures in rats (Gariboldi et al. 1996). In general, 
hyperpolarization of glutamatergic neurons by 5-HT1A receptors and depolarization of 
GABAergic neurons by 5-HT2C receptors as well as antagonists of 5-HT3 and 5-HT7 
receptors decrease the excitability in most networks involved in epilepsies (Bagdy et al. 
2007).               
 
Embryonic development of Dopaminergic and Serotonergic neurons: 
The embryonic development of the Central Nervous System (CNS) requires an 
orchestrated series of events tightly regulating the patterning and regionalization of the 
neural tube, as well as the proliferation, survival and differentiation of distinct neuronal 
populations. All these events are controlled by cascades of activation of transcription 
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factors that regulate the expression of specific subsets of genes in restricted regions and 
neuronal populations of the developing CNS. Among these transcription factors, 
homeobox-containing proteins play a crucial role, and altered expression of these 
factors can impact embryonic as well as adult CNS functions. In particular, homeobox-
containing genes have been described to crucially regulate differentiation of 
dopaminergic and serotonergic neurons during brain development. In the adult brain, 
dopaminergic and serotonergic neurons, respectively located in midbrain and hindbrain 
regions, diffusely innervate several forebrain areas, contributing to regulate several 
physiological functions including brain excitability. DA neurons are divided into ten 
distinct groups. The most prominent ones reside in the ventral midbrain (called A8, A9 
and A10), and in the diencephalon (groups A11-A15). The telencephalon contains two 
smaller groups of DA neurons, and these are restricted to the olfactory bulb (A16 
group) and retina (A17 group). Groups A1-A7 are noradrenergic. Mammalian 5-HT 
neurons are classically divided from anterior to posterior into nine cell groups (B9–B1, 
respectively). The more rostral 5-HT groups (B9-B5) reside in the midbrain and rostral 
hindbrain, whereas groups B4-B1 are located more caudally. Rostral group accounts for 
85% of all serotonergic neurons in the brain. The most rostral serotonergic neurons in 
the brainstem are located in the ventral tegmental area (Cordes 2005). 
Understanding the embryonic development of these neuronal subtypes is crucial to 
elucidate their physiological function in the adult brain. In the mammalian nervous 
system, individual populations of neurons develop in a stereotypic position identified by 
their coordinates along the antero-posterior (A/P) and dorso-ventral (D/V) axes of 
neural tube (Hynes et al. 1999; Tanabe et al. 1996). Three organizing centers, the mid-
hindbrain boundary (MHB or isthmus), the floorplate (FP), and the anterior neural ridge 
(ANR) control regionalization of the two main axes and specify the location and the cell 
fate of specific neuronal population within the brain fate map (Rubenstein et al. 1994).  
This is also true for dopaminergic (DA) and serotonergic (5-HT) neurons localized in 








Figure 8. Gene regulatory networks involved in DA and 5-HT neuron differentiation.  
(Top) Patterning signals in the developing brain. Sagittal view of an E11 mouse embryo neural tube; 
anterior is on the left. Expression of the secreted factors fibroblast growth factor 8 (Fgf8), Wnt1 and sonic 
hedgehog (Shh) is depicted at the MHB, in the anterior neural ridge and ventral diencephalon and within 
the floor/basal plate of the spinal cord, hindbrain, midbrain and caudal forebrain. Mesencephalic 
dopaminergic (DA) neurons are induced by a combination of Fgf8 and Shh (arrows). 5-HT neurons are 
specified by a combination of the same factors but they require an early inductive signal (Fgf4, not 
shown) derived from the anterior mesoderm during gastrulation. (Bottom) Gene expression patterns 
participating to DA and 5-HT neuron differentiation; anterior is on the left. Gbx2 expression maintains 
Fgf8 expression, whereas Otx2 and Gbx2/Fgf8 regulate each other negatively. Concomitantly, the 
expression territories of Fgf8, Wnt1, Engrailed and Pax genes become interdependent and establish a 
positive regulatory loop that is necessary to maintain MHB identity. The mid-diencephalic border is 
positioned by negative cross-regulations of Engrailed/Pax and Pax6 (not shown), whereas Fgf8 exerts a 
negative influence on the caudal expression of Hox genes (not shown). Later on, Shh induces the 
expression of Lmx1a and Msx1/2. While Lmx1a is sufficient to induce DA cell differentiation of ventral 
progenitors cells and induces the expression of Msx1/2, Msx1/2 is involved in the repression on the 
lateral progenitors cell fate (not shown). Midbrain DA neurons are specified dorso-ventrally by Shh 
signaling and antero-posteriorly by Otx2 signals, while 5-HT cells originate from precursors lacking the 
Otx2 signal. Shh signaling induces the expression of Nkx2.2, which is then essential for specification of 
5-HT neurons and ventral progenitor identity, conferring competence to become 5-HT neurons. Once 
positioning and identity of the neuronal precursors are determined, specific differentiation programs are 
activated in DA (Lmx1b, Pitx3, Nurr1) and 5-HT neurons (Lmx1b and Pet-1). Adapted from Prakash & 
Wurst 2004, Wurst & Bally-Cuif 2001, Tripathi et al. 2010. See text for details. Abbreviations: Di, 
diencephalons; Ms, mesencephalon; r, rhombomeres. 
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Regionalization of midbrain/hindbrain territory.  
The MHB is anatomically characterized as a neuroepithelial constriction between 
midbrain and hindbrain; however, as an organizing center, the MHB is the tissue that 
has the ability to recreate pattern when transplanted to a different region of the neural 
tube. Anatomical boundaries of this functional center have not yet been determined, so 
investigators have used genes that either are expressed specifically or have borders that 
terminate in the region at the early embryonic ages to define it. For this reason the 
borders of the MHB are only defined with the use of expression patterns of specific 
genes, which delineate its competence territory (Figure 8). These genes are expressed in 
the junction (e.g. En1, En2, Pax2, Pax5, Pax8, and Fgf8, Fgf17 and Fgf18), or cover a 
broad domain that terminate at the boundary between the mid- and hindbrain (e.g. Otx2 
and Gbx2). 
 
 On the basis of expression of the multiple MHB-associated genes, it has been 
determined that the MHB initially covers a broad region within the neural plate, 
occupying territories in both the presumptive midbrain and presumptive hindbrain. 
Between the headfold stage (>1 somite) and mid-gestation, it appears that this region 
gradually diminishes in size, subsequently occupying an area between the midbrain and 
hindbrain. By embryonic stage 7.5 (E7.5) in mouse, the transcription factors Otx2 and 
Gbx2 are expressed in a complementary fashion in the embryo: the border along their 
expression territories delineates the future junction between mesencephalon and 
metencephalon, the MHB (Figure 9). Slightly later, at E8, the transcription factor Pax2 
and the secreted molecule Wnt1 are expressed in broad, overlapping domains (Rowitch 
& McMahon, 1995). Wnt1 expression is largely restricted to the Otx2-positive territory, 
whereas Pax2 expression crosses the Otx2/Gbx2 border (Bally-Cuif, 1995). Shortly 
after, the transcription factors Engrailed 1 (En1) (at the 1-somite stage), Engrailed 2 
(En2) (at the 3–5-somite stage) (Davis & Joyner 1988; Davis et al. 1988) and Pax5 (at 
the 3/5-somite stage) (Asano & Gruss, 1992) are expressed across the Otx2/Gbx2 
border. The secreted factor fibroblast growth factor 8 (Fgf8) is similarly switched on at 
the 3–5 somite stage but is restricted to the caudal, Gbx2-positive side of the mes-
metencephalic junction (Crossley & Martin, 1995). 
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Otx1 and Otx2 are expressed rostral to the MHB (Simeone 1992, 1993; Millet 1996). 
Some others, such as Gbx2, are caudal to this boundary (Bulfone et al. 1993; von 
Bubnoff et al. 1995; Wassarman et al. 1997; Hidalgo-Sánchez et al. 1999), whereas 
others, such as En1 and En2 (Davis et al. 1988; Gardner et al. 1988) and three members 
of the Pax family (Pax2, Pax5 and Pax8; Asano and Gruss, 1992) are expressed at both 
sides of the boundary, forming a decreasing gradient in rostral and caudal directions 





Figure 9.  Dynamics of gene expression patterns at the mid-hindbrain border.  
Dorsal views of the mouse embryonic neural plate at a) 0-somite stage, b) 6-somite stage and c)| E10 
stage. Anterior is on the top. a) At the end of gastrulation (0 somites), the neural plate is broadly 
subdivided into an anterior domain that expresses Otx2 and a posterior domain that expresses Gbx2. The 
expression patterns of both genes meet at the mid-hindbrain border and form decreasing gradients in 
opposite directions. b) At 6 somites, the posterior border of Otx2 expression and the anterior border of 
Gbx2 expression have sharpened and abut each other. Wnt1 expression is initiated in the mesencephalon, 
and En1 (quickly followed by En2) and Pax2 are turned on across the Otx2–Gbx2 border. Slightly later, 
Fgf8 expression is recruited to the caudal side of the Otx2–Gbx2 border. c) At E10, the Otx2–Gbx2 
border identifies the midbrain/hindbrain boundary. The expression of Wnt1 and Fgf8 has become 
restricted to narrow rings encircling the neural tube on either side of this boundary. The domains of En1 
and Pax2 expression, which still overlap the boundary, have also become narrower, whereas En2, Pax5 
and Pax8 are expressed across most of the mid-hindbrain domain. (En, engrailed; Fgf8, fibroblast growth 
factor 8; Gbx2, gastrulation brain homeobox 2; Ms, mesencephalon; Mt, metencephalon; Otx2, 
orthodenticle homologue 2; P, prosencephalon; Pax, paired box; r, rhombomeres; hatched line, axis of 
symmetry). An arrow to the left of each panel indicates the position of the midbrain/hindbrain boundary. 




At early stages Fgf8, Wnt1 and Otx2 are expressed in the caudal midbrain regions that 
give rise to midbrain DA neurons. In contrast, Fgf8 and Gbx2, but not Wnt1, are 
expressed in the region that gives rise to rostral 5-HT progenitors (Figure 8). The 
transcription factors Engrailed1 (En1) and Engrailed2 (En2) are instead expressed in 
both caudal midbrain and anterior hindbrain. The expression domain of each gene 
reflects the role the gene plays in the formation of this territory. Otx2 and Gbx2 
expression domains are restricted to the anterior and posterior part of the neural tube 
and, by doing so, define positioning of MHB along the anterior-posterior axis; Wnt1 
and Fgf8 expression patterns are restricted to the mid-hindbrain junction in specular 
domains and are involved in the growth and maintenance of MHB cells; genes 
expressed across the entire mid- and hindbrain territory, such as Pax2, Pax5, En1/2, 
define the identity of this region, as a whole (Acampora et al. 1995, 1997; Suda et al. 
1997). The second organizing center of the midbrain/hindbrain region is the FP. Sonic 
hedgehog (Shh), a secreted glycoprotein and the key-signaling molecule of the FP, is 
mainly supplied to the neural tube by the ventral midline structures. In mice lacking Shh 
(Matsunaga et al. 2000), the nervous system shows abnormalities in the development of 
ventral midline structures like floor plate, notochord and the differentiation of ventral 
cell types. Shh provided by the floor plate and notochord transforms the dorsal into 
ventral fates and is required for the ventral cell types differentiation (Alexandre & 
Wassef 2005). Midbrain dopamine neurons and 5-HT neurons are induced close to the 
floor plate around E10. Dopamine neurons appear rostral to the MHB, whereas 5-HT 
neurons are generated caudally. Dopamine neurons of the tegmentum respond to a 
combination of Shh and Fgf8 while serotonin neurons of the pons require early Fgf4 
signalling, followed by Shh and Fgf8. However, Shh or Fgf8 or Fgf4 can not induce 
dopamine/serotonin neurons independently, indicating that an integration of 
dorsoventral and anteroposterior signals might be required (Ye et al. 1998). 
 
Development of mDA progenitors.  
The concomitant action of MHB and FP in the midbrain activates a combination of 
transcription factors including Otx2, Lmx1a/b, En1/2, Msx1/2, Ngn2 and Mash1, in a 
temporal sequence. The expression of Otx2, Lmx1b and En1/2 genes is already initiated 
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by E9.0 (Simeone et al. 1992; Ang et al. 1994; Simon et al. 2001; Smidt et al. 2000). 
Subsequently, Lmx1a and Msx1/2 expression turns on around E9.5, while Ngn2 and 
Mash1 are not expressed until E10.75 (Andersson et al. 2006a). The molecular 
mechanisms leading to the sequential activation of these genes is not understood. Shh 
can induce Lmx1a and Msx1/2 expression endogenously in mouse embryos one day 
later than the initiation of Shh expression (Echelard et al. 1993). These results suggest 
that Shh signalling induces another signal or factor that is required for the expression of 
Lmx1a and Msx1/2.  
 
Induction of the mDA neurons 
Birth dating studies demonstrate that mDA progenitors generate postmitotic immature 
mDA neurons between E9.5 and E13.5 in mice (Bayer et al. 1995). Immature mDA 
neurons induce Nurr1 expression (Zetterstrom et al. 1997) and En1/2 expression (Simon 
et al. 2001; Alberi et al. 2004) during this differentiation step (Figure 10). From E11.0 
onwards, immature mDA neurons continue to migrate radially on radial glial fibres and 
further differentiating into mDA neurons (Kawano et al. 1995). These neurons express 
Pitx3, TH (tyrosine hydroxylase) and aromatic amino acid decarboxylase (Aadc, the 
enzyme that converts DOPA into dopamine), in addition to the earlier markers 
expressed in immature mDA neurons. Ngn2, however, is not expressed in mature mDA 
neurons. Aadc mRNA transcripts are thought to be expressed already in immature mDA 




Figure 10. The sequential timing of transcription factor activation in mDA progenitors. The curved arrow 





Transcription factors required for mDA neuron development  
The roles of transcription factors, such as Nurr1, En1/2 and Ptx3, acting during the late 
differentiation step of the mDA lineage (described briefly above, see Figure 10 and 
Table 1) have been extensively reviewed (Goridis & Rohrer 2002; Riddle & Pollock 
2003; Wallen & Perlmann 2003; Simeone et al. 2005; Smits et al. 2006; Prakash et al., 
2006). However, the roles of the transcription factors that govern the specification and 
early differentiation of mDA progenitors have only recently started to emerge during 
the past decade (Table 1).  
 
 




Otx2 encodes a member of the bicoid sub-family of homeodomain-containing 
transcription factors that is widely expressed before gastrulation, but its expression 
becomes progressively restricted to the anterior third of the mouse embryo after E7.75 
(Simeone et al. 1993; Ang et al. 1994). Within the nervous system, Otx2 expression is 
restricted to the forebrain and midbrain between E8.5 and E12.5. In addition to these 
anterior brain region, expression is also detected in the rhombencephalon from E12.5 
onwards (Mallamaci et al. 1996). Otx2 is required for the formation of the forebrain and 
midbrain as a result of its role in the anterior visceral endoderm, where it functions to 
restrict posterior fates (Mallamaci et al. 1996; Perea-Gomez et al. 2001) (Simeone & 
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Acampora, 2001). Subsequently, Otx2 is also required for positioning the expression of 
Fgf8 and Wnt1 at the midbrain boundary (Brodski et al. 2003), and it limits the dorsal 
extent of Shh expression in the ventral midbrain (Puelles et al. 2003).  
 
The homeobox-containing transcription factor Otx2 has additional roles in specification 
and differentiation of mDA progenitor (Simeone et al. 2002; Simeone 2005). At the 
midbrain/hindbrain boundary, Otx2 specifies identity and number of dopaminergic 
versus serotonergic progenitors by antagonizing the fibroblast growth factor 8 (Fgf8) 
and sonic hedgehog (Shh) pathways and preventing ventral de-repression of the Nkx2.2 
transcription factor (Puelles et al. 2003; 2004; Prakash et al. 2006).  In dopaminergic 
progenitors, Otx2 is co-expressed with Engrailed 1 (En1) (Puelles et al. 2004).  
 
Several conditional Otx2 mouse mutants have been generated to delete Otx2 at different 
developmental stages. For example, conditional mutant mice were generated to 
inactivate Otx2 by a Cre recombinase expressed under the control of the En1 promoter 
(En1cre/+; Otx2flox/flox) (Figure 11). This strategy allowed to delete Otx2 only in the 
midbrain of En1Cre/+; Otx2flox/flox embryos; from E9.5 (around 25 somites) onwards, a 
virtually complete inactivation of Otx2 was detected in the ventral and caudal midbrain 
and functional Otx2 transcripts were confirmed to the dorsolateral aspect of the anterior 
midbrain (Puelles et al. 2004). 
 
Figure 11. Wild-type locus (thick upper line) is compared to three Otx2 mutant loci: after homologous 
recombination with the targeting vector (second line), after removal of the PGK neocassette (third line) 




In Otx2 conditional mutant mice (En1cre/+; Otx2flox/flox), midbrain dopaminergic neurons 
were greatly reduced in number and most of their precursors underwent 
neurotransmitter fate switch, generating 5-HT-positive neurons (Puelles et al. 2004) 
(Figure 12).  
 
Figure 12. Abnormalities in the ventral midbrain of En1Cre/+; Otx2flox/flox mutants. Th+ (A) and 5-HT (B) 
immunohistochemistry of DA and 5-HT area (Puelles et al., 2004). 
 
In these En1Cre/+; Otx2flox/flox mutant embryos, midbrain expression of Shh expands 
dorsally, whereas Fgf8 expression, which is normally restricted to the anterior 
hindbrain, shifts anteriorly into the midbrain (Puelles et al. 2004). Despite these 
changes in AP and DV patterning molecules, a small domain of midbrain tissue 
develops normally. Within this domain, expression of the homeodomain protein Nkx2.2 
expands ventrally into presumptive DA progenitors around E9.5, indicating that Otx2 is 
required for the repression of Nkx2.2 in these progenitors (Prakash et al. 2006). 
Interestingly, serotonergic neurons are generated ectopically in these Otx2 conditional 
mutants at the expense of TH+ mDA neurons. This alteration is maintained throughout 
life, since En1cre/+; Otx2flox/flox adult mice still display reduced DA and increased 5-HT 
levels in the striatum and cerebral cortex (Borgkvist et al. 2006).  
 
A different role for Otx2 in mDA progenitors was identified from studies of Nestin-Cre; 
Otx2flox/flox embryos (Vernay et al. 2005). In these conditional mutants, loss of Otx2 
protein from E10.5 onwards results in loss of expression of the proneural genes Ngn2 
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and Mash1 in ventral mDA progenitors. Subsequently, mDA neurons are missing at the 
ventral midline of the midbrain. These results indicate that Otx2, presumably via 
regulating the expression of Ngn2 and Mash1, is also required for the generation of 
mDA neurons.  
 
To study the role of Otx2 in the development of ventral midbrain dopaminergic 
neurons, mutant mice En1Cre/+; tOtx2ov was created (Omodei et al. 2008) in which Otx2 
was conditionally over-expressed by a Cre recombinase under the control of the En1 





Figure 13. Generation of mouse mutants overexpressing Otx2. The genomic position at the chromosome 
7 D2 region is shown in upper line whereas the tOtx2bov cassette is shown in second line, is inserted. 
Cre-mediated removal of the Neo-triple polyA stop cassette generates the tOtx2ov allele (third line). 
(from Omodei et al., 2008) 
 
These mice over-express Otx2 gene at rostral midbrain and hindbrain. The comparison 
between the control mice tOtx2ov and mutant mice En1Cre/+; tOtx2ov shows that mutant 
mice En1Cre/+;tOtx2ov in which Otx2 is overexpressed in hind brain region (prospective 
cerebellum) and over express throughout the midbrain. The Otx2 gene is essential for 
regulating the proliferation and differentiation of dopaminergic neurons. This over-
expression of Otx2 gene in these mutant mice was linked to the position occupied by 





Indeed, En1Cre/+;tOtx2ov mice have an increase of 35% of dopaminergic progenitors 
neuron in the VTA of the anterior, and more prominently in posterior mesencephalon 
(Omodei et al. 2008) (Figure 14). Moreover, Otx2 controls selectively the development 
of dopaminergic neurons which modulates the number along the anterior-posterior axis 
of the ventral midbrain. Otx2 overexpression induces a selective expansion of both 
mesDA progenitors and neurons, without affecting identity and size of adjacent 
progenitor domains or their post-mitotic progeny. The features of the oculomotor (OM) 
and red nucleus (RN) was similar in En1Cre/+; tOtx2ov  mice when compared with the 
tOtx2ov mice (Omodei et al. 2008). 
 
Figure 14. The overexpression of the Otx2 gene induces an increase in the number of dopaminergic 
neurons along the AP. Immnohistochemistry for  the dopaminergic marker tyrosine hydroxylase (TH) at 
the level of the ventral midbrain clearly demonstrate that number of TH+ neuron were less in tOtx2ov (A) 




Lmx1a and Lmx1b 
Lmx1a and Lmx1b are members of the family of LIM homeodomain transcription 
factors. Lmx1a expression begins at E9.5 in the ventral midbrain and then progressively 
expands dorsally (Andersson et al. 2006). By contrast, Lmx1b is expressed in the 
midbrain from E8.0 onwards (Smidt et al. 2000), but this expression becomes restricted 
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by E9.5 to the mid-hindbrain boundary, roof plate and the ventral midbrain, including 
the floor plate. At E9.5, Lmx1b expression encompasses more cells in the ventral 
midbrain than does Lmx1a, but that by E10.5 the expression domains of the two genes 
largely coincide. Since the expression of Lmx1a directly overlies a region where TH+ 
neurons develop at E11.5, Lmx1a expression has been proposed to mark the dorsal 
boundary of mDA progenitors (Andersson et al. 2006). 
 
Loss-of-function studies have shown that Lmx1b is required for the maintenance of 
TH+ mDA neurons. Recently, Lmx1a has been identified as a crucial determinant of 
mDA neuron fate development (Andersson et al. 2006). Overexpression of Lmx1a in 
the ventral midbrain promoted the generation of DA neurons over that of other neuronal 
subtypes. It is noteworthy that Lmx1a alone is not sufficient to induce mDA neurons, 
and that it functions cooperatively with ventral factors induced by the Shh pathway 
(Fig. 15).  
 
 
Figure 15. Model of mDA neuron specification. Shh induces Lmx1a and X (an unknown transcription 
factor) in mDA progenitors. Based on the timing of induction of endogenous Lmx1a expression 
compared with Shh expression, the induction of Lmx1a may be indirect. Lmx1a and X then act 
cooperatively to specify immature mDA neurons. Lmx1a in turn activates Msx1, which induces Ngn2. 
Ngn2 promotes neuronal differentiation and, perhaps, also the subtype specification of immature mDA 
neurons. In addition, Msx1 is required and is sufficient for the suppression of Nkx6.1 expression in DA 
progenitors. Dotted arrows indicate hypothetical functions that remain to be proven. This model is 
modified, from Andersson et al. 2006. 
 
Additional support for cooperative interactions between Shh and Lmx1a has come from 
studies using the differentiation of embryonic stem (ES) cells. Mouse ES cells 
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transfected with Lmx1a differentiate into DA neurons in the presence, but not in the 
absence, of Shh (Andersson et al. 2006). Conversely, Lmx1a knockdown by siRNA 
electroporation resulted in a loss of DA neurons, which was not compensated for by 
unperturbed expression of Lmx1b (Andersson et al. 2006). This hypothesis is consistent 
with the observation that Lmx1b is much less efficient than Lmx1a at promoting mDA 
neuron differentiation in ES cells (Andersson et al. 2006). 
 
Msx1 and Msx2 
The mouse Msx genes, Msx1, Msx2 and Msx3, encode homeodomain transcription 
factors and function as transcriptional repressors (Ramos & Robert 2005). Msx1 and 
Msx2 are expressed in DA progenitors in the ventral midbrain (Andersson et al. 2006). 
Msx3, by contrast, is expressed exclusively in the dorsal aspect of the neural tube in the 
mouse, caudal to the mid-hindbrain boundary (Shimeld et al. 1996; Wang et al. 1996). 
Msx1-/- embryos exhibit a strong reduction in the normal number of mDA neurons, 
probably as a result of the downregulation of Ngn2 expression (Andersson et al. 2006). 
Moreover, Msx1 is required to repress Nkx6.1 expression in ventral midbrain 
progenitors (Andersson et al. 2006). Premature expression of Msx1 in the midbrain in 
transgenic mice also leads to the precocious expression of Ngn2 and Nurr1, and to the 
downregulation of Shh in the floor plate, indicating that Msx1 sets the timing of mDA 
neuron generation possibly by inducing Ngn2 expression in ventral midbrain 
progenitors (Andersson et al. 2006). Given that Msx genes normally function as 
repressors, Msx1 may regulate the activity of a repressor of Ngn2 in mDA progenitors.  
 
Ngn2 and Mash1 
Proneural genes Mash1, Ngn2 and Ngn1 show an intricate pattern of expression in the 
ventral midbrain. Ngn2 and Mash1 are expressed in mDA progenitors, whereas Ngn1, 
Ngn2 and Mash1 are co-localized in the ventricular zone more dorsally (Kele et al. 
2006). Ngn2 is required for the generation of Nurr1+ immature mDA neurons, and 
probably also for their subsequent differentiation into TH+ mature mDA neurons 
(Andersson et al. 2006b; Kele et al. 2006). Although Mash1 by itself is not required for 
mDA neuron development, the loss of both Mash1 and Ngn2 in Mash1;Ngn2 double 
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mutant mouse embryos leads to a greater loss of mDA neurons than occurs in Ngn2 
single mutants, suggesting that Mash1 can partially compensate for the loss of Ngn2 
function in mDA progenitors. Accordingly, this results in a further rescue of Th+ 
neurons in Ngn2KIMash1/Mash1 embryos that express Mash1 under the control of the 
Ngn2 promoter (Kele et al. 2006). Ngn2 has a role in regulating generic neuronal, as 
well as subtype-specific, differentiation programs in other parts of the CNS (Bertrand et 
al. 2002). In other parts of the CNS, the role of Ngn2 in subtype specification has been 
demonstrated by the inability of other classes of proneural genes to compensate for 
Ngn2 activity (Bertrand et al. 2002). Mash1 is able to compensate partially for Ngn2 
function, as 60% of the normal number of mDA neurons are generated in 
Ngn2KIMash1/KIMash1 embryos. This partial compensation suggests some unique 
role for Ngn2 in specification of the mDA neuronal subtype. In addition, the expression 
of Ngn2, but not Mash1, in postmitotic DA neurons is consistent with an additional and 
unique role for Ngn2 in regulating later differentiation steps in immature mDA neurons. 
However, Ngn2 alone is insufficient to promote the ectopic expression of DA neuron 
markers and the generation of ectopic DA neurons (Kele et al. 2006).  
 
The Engrailed (En) homeobox genes are one of the most widely studied group of 
transcription factors, described and investigated in a variety of species. The En genes 
are involved in regionalisation during early embryogenesis (Hidalgo, 1996; Joyner, 
1996), and later in the specification of certain neuronal populations (Lundell et al. 1996; 
Simon et al. 2001). During early embryogenesis, they are required for the maintenance 
of Fgf8 expression in the midbrain and hindbrain. During later development and 
throughout life, the two genes are required for the survival and maintenance of mesDA 
neurons in a cell-autonomous and gene dose-dependent manner. In mouse embryo 
expression of these genes was first detected at 8 day. In vertebrate species, two 
homologs of Engrailed exist, En1 and En2. At the protein level, the sequence 
differences between homologs and paralogs are significant, while homeobox domain is 
highly conserved. En1 has roles in generation of mid-hindbrain precursor cells and in 
signaling normal development of the limbs and sternum (Wurst 1994). Engrailed-1 is a 
target of Wnt-1 signaling pathway in the midbrain development. En1 mutant mice die at 
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birth with a large mid-hindbrain deletion, whereas En2 mutants are viable, with 
cerebellar defects. En1 mutant phenotype was rescued by replacement of En1 with En2 
(Hanks et al. 1995). Engrailed-2 was ectopically expressed in cerebellar Purkinje cells 
from the late embryonic stage into adulthood (Baader et al. 1999). 
 
The En2 mutation was created by homologous recombination, resulting in the 
replacement of approximately 1 kb of the En2 gene (300 bp of intron and 700 bp of the 





Figure 16. Structure of the En-2 protein and wild-type and mutant loci- The normal En-2 protein product 
is shown schematically at the top with the four engrailed conserved domains depicted as stippled boxes. 
The conserved domains NH2- and COOH-terminal of the homeobox are 17 and 21 amino acids, 
respectively. The arrow indicates the position of the intron in the En-2 gene. The En-2 wild-type (middle) 
and mutant (bottom) loci are shown schematically with the 5' end to the left. The En-2 exons are marked 
as thick-lined rectangles with the translated sequences stippled and the homeobox solid. The neo 
containing vector is shown as a thin-lined rectangle and Pr indicates the 500-bp human P-actin promoter 
sequences. The one transcript of the wild-type En-2 gene and two transcripts of the mutant En-2 locus 
from both the En-2 promoter and the 1-actin promoter are indicated below the loci with narrow rectangles 
indicating the exon sequences. The restriction sites are B, Barn HI and Bg, Bgl II. (Bg) indicates the Bgl 
II restriction site destroyed in making the mutation (from Joyner et al., 1991). 
 
 
For generation of En1+/-/En2-/- or En1/tau-LacZ+/-/En2-/- mice, first En1/tau-LacZ  mice 
were generated by a “knock-in” strategy in which the first 71 codons, including the start 
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codon, were replaced by a tau-LacZ sequence (Callahan and Thomas, 1994) and 
resulted in an En1 null allele. The construct and procedures are described below 
(Saueressig et al. 1999). Parental lines for producing the mutant mice deficient for both 
En1 and En2 were kept as En1+/-/En2-/- or En1/tau-LacZ+/-/En2-/- (Simon et al. 2001) 
(Figure 17) 
 
Figure 17.  Structure of the mouse En1 locus- The En1/tau-LacZ  knock-in targeting vector is shown 
below. Abbreviations: B, BamHI; C, ClaI; H, HindIII; R, EcoRI; X, XbaI; neo, PGKneopA G418 
resistance cassette used for positive selection flanked by loxP recombination sites (triangles); T-lacZ, 
coding region of the tau-lacZ fusion gene; pA, SV40 polyadenylation signal. DNA probe: A 0.7 kb 
EcoR1-HindIII fragment from the 3′ end of the En1 gene was used to screen ES cells for homologous 
recombinants (Saueressig et al. 1999). 
 
The single-null mutants for either En1 (En1-/-) or En2 (En2-/-) show no significant 
alterations in the organization of the mesDA system at birth. En1-/-, En1-/-; En2+/- and 
En1-/-; En2-/- mice die at birth and show a gene-dose- dependent reduction of mesDA 
neurons ((Simon et al. 2001). Mice of other Engrailed genotypes are viable and fertile. 
Among these, En1+/-, En1+/-/En2+/-, En2+/-, and En2-/- mice displayed a wild-type-like 
distribution of the neurons at all ages. En1+/-; En2-/- (EnHT) mice are viable and fertile 
and showed a specific loss of DA neurons in the SN.  
 
In the EnHT mice, the numbers of mesDA neurons continued to decrease until 3 months 
after birth while the distribution and number of mesDA neurons were stablized in En2-/-  
    
mice at all age. Indeed, from 3 months after birth, the mutants had on average 32.6% 
fewer mesDA neurons than their En2-/- litter-mate controls (Sgado et al. 2006) (figure 
18). Moreover, no major defect in DA and 5-HT systems has been found in the En2-/- 
mice so  for this purpose En2-/- mice has been considered as control littermates (Sgado 
et al. 2006). In the open field test, a general assessment of locomotor and exploratory 
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behavior, EnHT mice were not impaired at 8 months; however, by 18 months of age, 
they showed a significant reduction in forward locomotion compared with En2-/- 
littermate controls and to their own performance at 8 months, whereas in En2-/- mice, 
locomotion was not significantly altered (Sgado et al. 2006). 
 
 
Figure 18. Progressive postnatal degeneration of dopaminergic cells of the substantia nigra-TH 
immunostaining on coronal brain section at P0 (A, A’), P30 (C, C’), and 3months (E, E’) of En2-/-and 
EnHT mutant mice on the level of the substantia nigra. (Scale bars: 0.5mm) (from Sgadò et al. 2006). 
 
 
Development of hind brain serotonergic neurons. 
Genetic and transplantation experiments have demonstrated that the sonic hedgehog 
(Shh) signal, which is emitted by the notochord and the floorplate (midline of the neural 
tube), is required to induce 5-HT cell fate. Although 5-HT neurons are born near the 
floorplate, they migrate to specific positions along the dorso-ventral axis as the raphe 
nuclei are formed (refs?). 
 
Induction of the hindbrain 5-HT neurons 
The inductive requirements of 5-HT neurons of the DRN (dorsal raphe nucleus) differ 
from those of the MRN (medial raphe nucleus). The first 5-HT neurons that are born in 
r1 (rhombomere 1) become the 5-HT neurons of the DRN, and may be particularly 
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dependent on Fgf8 or another signal from the mid/hindbrain organizer, also known as 
the isthmus. When Fgf8 expression is reduced by shifting expression of the 
homeodomain gene Otx2 caudally, 5-HT neurons in the DRN are reduced (Brodski 
2003). Conversely, if the expression of the Gbx2 homeodomain gene is shifted rostrally 
and Fgf8 expression extended, the DRN is enlarged (Wassarman et al. 1997). The 5-HT 
neurons of the DRN also rely on a non-cell autonomous, dosage-sensitive function of 
the En1 and En2 transcription factors, which again could be mediated by altered Fgf8 
expression (Cordes 2005). Taken together, these data appear to suggest that high early 
levels of Fgf8 or another isthmus-specific signal may be required to induce 5-HT 
neurons in the DRN, while lower Fgf8 levels may suffice to induce 5-HT neurons in the 
MRN. 
 
Transcriptional determinants of early 5-HT neuron specification 
The transcription factors involved in 5-HT neuron development can be roughly divided 
into two broad classes:  
1) Nkx2.2, Nkx6.1, and Mash1 are required to generate 5-HT precursors,  
2) Mash1, Gata2, Gata3, Lmx1b, and Pet1 are required for -5-HT subtype selection and  
    5-HT neuron terminal differentiation. 
 
Nkx2.2 homeodomain transcription factor acts downstream of Shh signaling. Nkx2.2 is 
essential for initiating the specification of all 5-HT neurons in the raphe except for those 
from the DRN. In Nkx2.2–/– mice, only dorsal raphe 5-HT neurons are present, and all 
others are missing. Nkx2.2 is thought to promote 5-HT neuron differentiation in part by 
down regulating the homeodomain transcription factor Phox2b. During 5-HT neuron 
development, Nkx2.2 does collaborate with the related homeodomain transcription 
factor Nkx6.1, which is expressed more broadly than Nkx2.2 in the ventral hindbrain. 
Nkx2.2 and Nkx6.1 together direct Gata2 and Gata3 expression and 5-HT neuron 
specification. As already described, Nkx2.2 expression is negatively controlled by Otx2 
in presumptive DA progenitors. De-repression of Nkx2.2 in these progenitors due to 
conditional knockout of Otx2 in these cells results in ectopic generation of serotonergic 




Nkx6.1 is a Shh-inducible HD transcription factor similar to Nkx2.2 but with a broader 
expression domain (Briscoe et al. 2000). Shh regulates Gata2 and 5-HT expression in r1 
through a combination of Nkx2.2 and high Nkx6.1 signals (Figure 19). Down-
regulation of Nkx6.1 by antisense morpholinos in the hindbrain leads to loss of Gata2, 
Gata3, and Pet1 expression and the absence of 5-HT neurons (Craven et al. 2004). The 
Gata2 and Gata3 zinc finger transcription factors are required in a global 5-HT neuron-
specific and a 5-HT cluster-specific manner, respectively (Cordes et al. 2005) (Figure 
19). Ectopic expression of either Gata protein is sufficient to induce 5-HT neurons in r1 
of the hindbrain, and this occurs downstream of Nkx2.2/Nkx6.1, and upstream of 
Lmx1b /Pet1 (Craven et al. 2004). Gata3 is expressed in both clusters of 5-HT neurons 
starting at E10.5–11.5, but it is only required for development of 5-HT neurons in the 
caudal raphe nuclei (Pattyn et al. 2004). In Gata3–/– embryos, a normal number of 5-
HT precursor cells are formed, but a striking gradient of diminishing requirement for 
Gata3 from caudal to rostral can be seen (Pattyn et al. 2004). 
 
Figure 19. The specification of rostral 5-HT neurons in the vertebrate hindbrain. Shh signaling in the 
ventral midline activates the Nkx2.2 and Nkx6.1 in the rostral hindbrain. Nkx2.2 and Nkx6.1 are 
sufficient to activate expression of Gata2 and Gata3, which can positively regulate each other. Gata2, in 
turn, is necessary and sufficient to activate Lmx1b and Pet1, and to specify 5-HT neurons. Gata2 may 
activate additional transcription factors and/or may be required to directly cooperate with Lmx1b and 
Pet1 in 5-HT specification (modified from Cordes 2005) 
 
Two lines of evidence suggest that terminal differentiation of 5-HT neurons depends on 
Lmx1b. First, no expression of differentiated 5-HT neuronal markers such as 5-HT, 
serotonin transporter (SERT) and Pet1 are detected in the Lmx1b-/- mutant mice. 
Second, most Lmx1b–/– cells exhibit aberrant migratory behavior at a late stage of their 
development. Lmx1b-positive 5-HT precursors were derived from Nkx2-2-expressing 
precursors. Lmx1b-mediated event provides a critical step that couples the Nkx2-2-
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dependent early specification of neurons with the Pet1-dependent terminal 
differentiation of 5-HT neurons (Ding et al.  2003). Pet1 working synergistically with 
GATA3 in the caudal raphe nuclei and other unidentified Pet1-independent 
transcription factors that are downstream to Lmx1b, control the terminal differentiation 






























AIM OF THESIS 
 
 
The aim of this thesis was to investigate whether an altered embryonic development of 
dopaminergic and serotonergic neurons could alter seizure susceptibility in the adult 
life. To this purpose, a series of classical and conditional knockout mouse lines with 
targeted inactivation of Otx2 and En genes were studied. The mouse lines used in this 
study are as follow. 
 
1) En1cre/+; Otx2flox/flox conditional mutant mice in which midbrain dopaminergic 
neurons were greatly reduced and 5-HT positive neurons increased.  
2)  En1Cre/+;tOtx2ov condition mutant mice in which dopaminergic neurons were greatly 
increased. 
3) En1+/-; En2-/-(EnHT) mice which have progressive postnatal degeneration of 
dopaminergic cells. 
 
Using these mouse lines, we addressed how an altered development of dopamine and 
serotonin neurotransmitter pathways can markedly affect seizure susceptibility in the 
adult brain. As a seizure model, systemic administration of the glutamate agonist kainic 
acid (KA) was used. Behavioural observation of KA-induced seizures was performed, 
and induction of immediate early genes (IEGs) like c-fos and c-jun was also followed 
after KA seizures. In order to assess whether altered susceptibility to KA-induced 
seizure in these mice also resulted in altered susceptibility to long-term damage, 













The generation and genotyping of En1Cre/+; Otx2flox/flox (Puelles et al., 2003; 2004), 
En1Cre/+;tOtx2ov (Omodei et al., 2008), EnHT (Sgadò et al., 2006) and En2-/- (Joyner et 
al., 1991) mutant mice have been already reported.The two strains (En1Cre/+ xOtx2flox/+ 
and En1Cre/+  xtOtx2ov) were mated to generate parental mice (En1Cre/+; 
Otx2flox/+,Otx2flox/flox, En1Cre/+;tOtx2ov and tOtx2ov).Otx2flox/flox and tOtx2ovmice were 
chosen as controls, as they do not show any anatomical or behavioral abnormality 
respect to wild-type animals (Puelles et al. 2003; Borgkvist et al. 2006, Omodei et al. 
2008). Adult (3-6 months old; weight = 20-35 g) mice of both sexes were used. The 
EnHT and En2 mutants (mixed 129Sv x Swiss–Webster genetic background) were 
crossed at least three times into a C57BL/6 background. Adult (5 months old; weight = 
25-35 g) male mice were used in all experiments. Animals were housed in a 12 hr 
light/dark cycle with food and water available ad libitum. Experiments were conducted 
in conformity with the European Communities Council Directive of 24 November 1986 
(86/609/EEC). Additional details on the mouse strains used in our studies can be found 
in Tripathi et al., 2008, 2009. 
 
 
Drug treatments.  
For seizure studies, Otx2flox/flox (n= 10), En1Cre/+; Otx2flox/flox (n= 10), En1Cre/+;tOtx2ov 
(n= 7), tOtx2ov (n=7), tOtx2ov (n=7), EnHT (n=8), Wild type (n=8), En2-/- (n= 12) mice 
received a single intraperitoneal injection of kainic acid (KA; Ocean Produce 
International, Shelburne, NS, Canada; dissolved in saline) at 20 mg/kg.For pCPA+KA 
treatments, mice (n = 10 per genotype), received the same dose of KA 16 hr after the 
last pCPA injection. All experiments were performed blind to genotype and treatment. 
To deplete 5-HT, Otx2 conditional mutant mice and their controls (n = 5 per genotype) 
received pCPA (4-chloro-L-phenylalanine hydrochloride, Sigma; 10 mg/ml stock in 
saline) twice a day (≈ 10:00 and 18:00 hr) at a dose of 100 mg/kg (i.p.) for 3 
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consecutive days (Rantamäki et al., 2007). Five Otx2flox/floxand five En1Cre/+; 
Otx2flox/floxmice received saline with the same schedule and served as controls. Sixteen 
hr after the last pCPA/saline injection, brains were dissectedOne hemisphere was used 
for immunohistochemistry, and the other for HPLC. 
 
Behavioural observation of KA-induced seizures.  
Seizures were scored according to Racine (1972): stage 0: normal behavior; stage 1: 
immobility; stage 2: forelimb and/or tail extension, rigid posture; stage 3: repetitive 
movements, head bobbing; stage 4: forelimb clonus with rearing and falling (limbic 
motor seizure); stage 5: continuous rearing and falling; stage 6: severe whole body 
convulsions (tonic-clonic seizures); stage 7: death. For each animal, seizure severity 
was scored every 20 min for 2 hr after KA administration. The maximum rating scale 
values reached by each animal over each 20 min interval were used to calculate the 
rating scale value (± SE) for each treatment group. Statistical analysis was performed 
by two-way repeated measures ANOVA followed by post-hoc Holm-Sidak test. 
 
5-HT dosage by HPLC.  
5-HT was measured according to Atkinson et al. (2006) in the Otx2flox/flox and En1Cre/+; 
Otx2flox/flox mice. Brain areas (pons/ventral midbrain, hippocampus and cerebral cortex) 
were dissected on ice, weighed to the mg sensitivity and extracted with a buffer 
containing 8.2% ascorbic acid, 1.64% Na2S2O5, 0.83M HClO4. Extraction buffer 
volume (in μl) corresponded to three times the weight in mg of the specimen. 
Homogenates were centrifuged (30 min, 18,000 rpm, 4°C) and supernatants were used 
as samples for HPLC. Standard solutions were prepared dissolving 5-HT and 
tryptophan  (Sigma) in extraction buffer. Twenty μl of samples or standards were 
injected into a Synergy Hydro-RP separation column, fitted with a C18 cartridge 
column (Phenomenex, Bologna, Italy). The column was eluted isocratically (0.8 
ml/min, 29°C) with mobile phase (100 mM ammonium acetate pH 4.5: methanol, 
12.5:1 v/v) in a Waters Alliance HPLC apparatus. Detection was performed with a 
Waters 474 scanning fluorescence detector (excitation and emission wavelengths: 290 
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and 337 nm, respectively) and data analysis was performed with Waters Millenium 
software. Values (± SE) were reported as pmol of 5-HT per mg of wet tissue. Statistical 
analysis was performed by one-way ANOVA followed by post-hoc Tukey test. 
 
In situ hybridization.  
In situ hybridization experiments were performed to detect IEGs activation following 
KA seizures. Mice were killed at 2 hr (for En1Cre/+; Otx2flox/flox) or 3 hr (for En1Cre/+; 
tOtx2ov, tOtx2ov, EnHT and En2-/-) after KA injection, and brains were rapidly removed 
and frozen on dry ice. Coronal cryostat sections (20 μm thick) were fixed in 4% 
paraformaldehyde. Non-radioactive in situ hybridization was performed as previously 
described (Antonucci et al. 2008) using a digoxigenin labeled c-fos and c-jun 
riboprobes (Bozzi et al. 2000). Signal was detected by alkaline phosphatase-conjugated 
anti-digoxigenin antibody followed by alkaline phosphatase staining. The specificity of 
the results was confirmed by the use of sense riboprobes which gave no detectable 
signal (not shown). Brain areas were identified according to Franklin and Paxinos 
(1997). To quantify the level of c-fos and c-jun mRNAs, digital images of three 
matching sections per animal, taken at the level of the dorsal hippocampus, were 
analysed using the Image J free software (http://rsb.info.nih.gov/ij/). For each section, 
signal intensity was measured in ten different circular windows (area = 0.01 mm2) 
placed in layers 2-3 and 5-6 of the parietal/temporal cortex. Mean signal intensity was 
divided by the background labeling calculated in the corpus callosum. Statistical 
analysis was performed by Student’s t-test. 
 
Immunohistochemistry.  
Brains were fixed by immersion in 4% paraformaldehyde, cryoprotected in 30% 
sucrose/1xPBS and coronal sections (40 μm thick) were cut on a freezing microtome. 
Serial sections were incubated overnight with different antibodies (anti-5-HT, anti-
SERT, anti-NeuN, anti-NPY, anti-Parvalbumin, anti-Somatostatin, see the table 2 for 
dilution), diluted in a PBS solution containing 1% serum and 0.1% Triton X-100. 
Sections were then reacted with a biotinylated secondary antibody (Vector Laboratories, 
 42
 
Burlingame, CA) followed by avidin-biotin-peroxidase complex (ABC kit, Vector 
Laboratories) and diaminobenzidine reaction. 
Quantitative analyses of 5-HT immuhistochemistry experiments in control and Otx2 
mutant mice were performed on digitized images (10x primary magnification) by using 
the Metamorph software. Three sections at the level of the ventral tegmental area 
(VTA), CA3 subfield (dorsal hippocampus) and dorsal raphe nucleus were taken from 
each animal (3-5 animals per genotype). To count 5-HT positive cells in the VTA, four 
squared counting boxes (75 mμ per side) were taken per section. 5-HT staining in the 
CA3 pyramidal layer was measured in 20 sampling windows (approximately the size of 
one cell) per section, and obtained values (grey levels) were divided by the background 
value measured in the callosum. 5-HT staining per cell in the dorsal raphe nucleus was 
measured in 10 cell bodies per section, and obtained values (grey levels) were divided 
by the background value measured in the callosum. Statistical analyses were performed 
by one-way ANOVA followed by appropriate post-hoc test 
 
Neuronal damage in WT and En2-/- mice was qualitatively in CA1/CA3 areas according 
to the following scale (Bozzi et al. 2000; Bozzi and Borrelli, 2002; Cilio et al. 2001): 
little damage, presence of scattered degenerated cells; mild damage, small areas with 
degenerated cells and/or tissue sclerosis; severe damage, extended areas of neuronal and 
fiber degeneration, accompanied by tissue sclerosis. Neurodegeneration was also 
confirmed by Nissl staining, performed on sections adjacent to those used for NeuN 
histochemistry. 
 
Quantitative analyses of PV, SOM and NPY-positive cells in WT En2-/- mice were 
performed on digitized images (20x primary magnification) by using the Metamorph 
software. Three sections at the level of the dorsal hippocampus and overlying 
somatosensory cortex were taken from each animal (3-5 animals per genotype). To 
count positive cells in cortical layers 2-3 and 5-6, six squared counting boxes (100 mμ 
per side) were taken per section. To count positive cells in the hilus, all cells were 
counted within each hilus, and values were expressed as the number of cells per hilar 





Antibody Company/Species/Serotype Dilution 
5-HT Sigma-Aldrich, rabbit, polyclonal 1:5000 
5-HT Millipore, rat/monoclonal 1:200 
SERT Calbiochem, rabbit, polyclonal 1:5000 
NeuN Chemicon, mouse, monoclonal 1:500 
NPY Bachem, rabbit, polyclonal 1:5000 
Parvalbumin Sigma –Aldrich, mouse, monoclonal 1:5000 
Somatostatin Bachem, rabbit, polyclonal 1:5000  
Table 2. Antibodies used during the immunohistochemistry experiments and their respective dilution. 
 
Quantitative RT-PCR for En2 mRNA 
Total RNAs were extracted by Trizol© reagent (Invitrogen) from the cerebral cortex, 
hippocampus, ventral midbrain and cerebellum of four adult WT mice and pooled. 
DNAse-treated RNAs were purified and concentrated with Nucleospin RNA XS 
columns (Macherey-Nagel). cDNA for real-time PCR was synthesized from RNA (2 
μg) using the Reverse Transcriptase Core kit (Eurogentec) according to the 
manufacturer’s instructions. Quantitative PCR was performed using a Rotor-gene 
2000™ thermal cycler with real-time detection of fluorescence (Corbett Research, 
Sydney, Australia). PCR reactions were conducted in a volume of 25 μl using the 
MESA GREEN qPCR kit (Eurogentec) according to manufacturer’s instructions. 
Mouse mitochondrial ribosomal protein L41 (Mrpl41) was used as a standard for 
quantification. Primers (Sigma Genosys, UK) were as follows: En2 forward 5’-
AGAGAGGGCGCAGTTCTTTG-3’; En2 reverse 5’-GACACAGACGCAGACACAC-
3’ (GenBank accession no. NM_010134.3; expected fragment size: 151 base pairs); L41 
forward 5’-GGTTCTCCCTTTCTCCCTTG-3’; L41 reverse 5’-GCACCCCGACTCTT-
AGTGAA-3’ (GenBank accession no. NM_001031808.2; expected fragment size: 179 
base pairs). Each PCR cycle consisted of denaturation for 10 s at 94 ºC, annealing for 
20 s at 60 ºC (58 ºC for L41), and extension for 30 s at 72 ºC. The fluorescence intensity 
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of SYBR green I was read and acquired at 72 ºC after completion of the extension step 
of each cycle. PCR conditions for individual primer sets were optimised by varying 
template cDNA and magnesium ion concentration in order to obtain amplifications 
yielding a single product and melt curves with a single uniform peak. Quantification of 
individual transcripts was performed using the dComparative QuantitationT software 
supplied with Rotor-gene. En2 and L41 mRNA concentrations in ventral midbrain, 
cerebral cortex and hippocampus were referred to those detected in the cerebellum 
(comparative quantitation). Ratios of En2 mRNA/L41 mRNA comparative 
concentrations were then calculated and plotted as the average of three different 



























En1Cre/+; Otx2flox/flox mice 
 
Distribution of 5-HT and 5-HT transporter (SERT) in the ventral midbrain and 
hippocampus  
We first analyzed the distribution of 5-HT and 5-HT transporter (SERT) in the ventral 
midbrain and hippocampus of drug-free En1Cre/+; Otx2flox/flox mutant and Otx2flox/flox 
control adult mice.  
 
C 
Mice 5-HT cells in VTA 
(cells/area)  
5-HT staining in the CA3 
(staining density/cell)   
Otx2flox/flox mice 7 ± 1 1.155 
En1Cre/+; Otx2flox/flox 
mice 
14 ± 3 1.491 
 
Figure 20. 5-HT is increased and SERT is decreased in the ventral midbrain and hippocampus of Otx2 
conditional mutant mice. Figures show coronal sections through the ventral tegmental area of the 
midbrain (top) and CA3 region of the hippocampus (bottom) from Otx2flox/flox and En1Cre/+; Otx2flox/flox 
mice, stained with 5-HT (A) and SERT (B) antibodies. Quantitative analysis confirmed the increased 
number of 5-HT cells in the VTA and 5-HT staining in the CA3 area of En1Cre/+; Otx2flox/flox mice (C). 
Scale bar = 150 μm. 
 
 
Immunohistochemistry experiments confirmed the presence of 5-HT-positive neurons 
in the ventral midbrain of En1Cre/+; Otx2flox/flox but not Otx2flox/flox mice (Figure 20A). In 
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the hippocampus, 5-HT staining was increased in the CA3 area of Otx2 conditional 
mutant mice, as compared to control mice (Figure 20A). These findings were confirmed 
by quantitative analysis. A small number of 5-HT positive cells were detected in the 
ventral tegmental area (VTA) of Otx2flox/flox mice. These cells had a very small size and 
a rounded shape, suggesting that they were likely platelets (Brenner et al. 2007). 
Conversely, a higher number of 5-HT positive cells, clearly identifiable as neurons, was 
detected in the VTA of En1Cre/+; Otx2flox/flox mice. Quantitative analysis confirmed the 
increased number of 5-HT cells in mutant mice (mean number of cells per counting 
box, ± SE: control, 7 ± 1; mutant, 14 ± 3; n = 36 counting boxes from 3 mice per 
genotype; t-test, p<0.05) (Figure 20C). Quantitative analysis also confirmed increased  
5-HT staining in the CA3 area of Otx2 conditional mutant mice, as compared to control 
mice (median value of 5-HT staining / background: control, 1.155; mutant, 1.491; n = 
180 sampling windows from 3 mice per genotype; Mann-Whitney rank sum test, 
p<0.001) (Figure 20C). Conversely, SERT levels in serotonergic fibers were markedly 
reduced in these areas in En1Cre/+; Otx2flox/flox mice, when compared to control animals 
(Figure 20B). 
 
5-HT levels in ventral midbrain and hippocampus 
We next determined the 5-HT levels in different brain areas of En1Cre/+; 
Otx2flox/flox and Otx2flox/flox mice (n = 5 per genotype). HPLC analysis in Otx2 conditional 
mutant mice revealed a significant increase of 5-HT content in the pons/ventral 
midbrain, as compared to control mice (Figure 21A, saline-treated groups; one-way 
ANOVA, p<0.05; post-hoc Tukey test control vs. mutant, p<0.05). A slight but not 
significant increase of 5-HT content was detected in the whole hippocampus of 
En1Cre/+; Otx2flox/flox, as compared to Otx2flox/flox mice (one-way ANOVA, p>0.05). 
According to a previous study (Borgkvist et al. 2006), 5-HT levels were also increased 
in the cerebral cortex of mutant mice (pmol 5-HT/ mg tissue: saline-treated Otx2flox/flox, 
1.71±0.19; saline-treated En1Cre/+; Otx2flox/flox, 4.8±0.77; one-way ANOVA, p<0.05; 
post-hoc Tukey test, p<0.05). In both control and Otx2 conditional mutant mice (n = 5 
per genotype), prolonged treatment with the 5-HT synthesis inhibitor para-
chlorophenylalanine (pCPA) significantly reduced 5-HT levels in the pons, ventral 
 47
 
midbrain and hippocampus (Figure 21A). pCPA also decreased 5-HT content in the 
cerebral cortex in both genotypes (pmol 5-HT/ mg tissue: pCPA-treated Otx2flox/flox, 
0.98±0.16; pCPA-treated En1Cre/+; Otx2flox/flox, 1.7±0.5; one-way ANOVA, p < 0.05; 
post-hoc Tukey test, pCPA vs. saline of same genotype, p<0.05). 5-HT levels in pCPA-
treated En1Cre/+; Otx2flox/flox mice did not significantly differ from those detected in 
saline-treated Otx2flox/flox animals (Figure 21A). 
 
 
  D 
Mice Treatment 5-HT staining per cell in 
the DRN (arbitrary units) 
Otx2flox/flox Saline 1.90±0.02 
En1Cre/+; Otx2flox/flox  Saline 2.22±0.02 
Otx2flox/flox  pCPA 1.65±0.03 
En1Cre/+; Otx2flox/flox pCPA 1.63±0.03 
 
Figure 21. 5-HT depletion in control and Otx2 conditional mutant mice. A) HPLC determination of 5-HT 
content in the pons/ventral midbrain (top) and hippocampus (bottom) from Otx2flox/flox and En1Cre/+; 
Otx2flox/flox mice, following a 3 days treatment with saline or pCPA. Data are reported as mean ±  SE (n = 
5 animals per group). *, p<0.05, post-hoc Tukey test. B) Representative low-magnification images 
showing 5-HT immunostaining on sagittal brain sections from control and Otx2 conditional mutant mice, 
treated with saline or pCPA. Genotypes and treatments are as indicated. Abbreviations: bf, basal 
forebrain; ctx, cerebral cortex; dr, dorsal raphe nucleus; p, pons; vmb, ventral midbrain. Scale bar = 3.4 
mm. C) Representative high-magnification images showing 5-HT immunostaining in the dorsal raphe 
nucleus from control and Otx2 conditional mutant mice, treated with saline or pCPA. D) Quantitative 
analysis shows Mean values (± SE) of 5-HT staining per cell (normalized to background) in the dorsal 
raphe nucleus of En1Cre/+; Otx2flox/flox and Otx2flox/flox mice, treated with saline or pCPA. Genotypes and 




5-HT immunohistochemistry performed on brain sagittal sections from saline- 
and pCPA-treated Otx2flox/flox and En1Cre/+; Otx2flox/flox mice confirmed these findings. 
According to our previous results (Figure 21A, B and Borgkvist et al. 2006), increased 
5-HT staining was detected in several areas including ventral midbrain, basal forebrain, 
cerebral cortex (Figure 21B) and pons (raphe nuclei, Figure 21B, C) of saline-treated 
En1Cre/+; Otx2flox/flox mutants, as compared to saline-treated Otx2flox/flox controls. 
Treatment with pCPA markedly reduced 5-HT staining in all these areas in both 
genotypes (Figure 21B, C, D). Quantitative analysis of 5-HT staining per cell in the 
dorsal raphe nucleus confirmed these findings (Figure 21D). Mean values (± SE) of 5-
HT staining per cell (normalized to background) were as follows: Otx2flox/flox saline, 
1.90±0.02; En1Cre/+; Otx2flox/flox saline, 2.22±0.02; Otx2flox/flox + pCPA, 1.65±0.03; 
En1Cre/+; Otx2flox/flox + pCPA, 1.63±0.03 (n = 150 cells from 5 animals per group) 
(Figure 21D). Statistical analysis confirmed that 5-HT levels were increased in saline-
treated mutant mice, as compared to controls (one-way ANOVA, p<0.001; post hoc 
Holm-Sidak test, p<0.001) and that pCPA significantly decreased 5-HT staining in both 
genotypes (one-way ANOVA, p<0.001; post hoc Holm-Sidak test, p<0.001, control 
saline vs. control pCPA, and mutant saline vs. mutant pCPA). No difference was 
detected between control and mutant mice treated with pCPA (one-way ANOVA, 
p>0.05; post hoc Holm-Sidak test, p>0.05). 
 
5-HT levels alter seizure susceptibility 
We next investigated whether increased 5-HT levels might alter seizure 
susceptibility in Otx2 conditional mutant mice. Adult En1Cre/+; Otx2flox/flox and 
Otx2flox/flox mice (n = 10 per genotype) received a single systemic injection of KA (20 
mg/kg) and were observed for 2 hr. KA treatment had a strong convulsant effect in 
Otx2flox/flox mice. All mice showed initial immobility, rapidly followed by repeated 
generalized (stage 4-6) seizures (Figure 22). The mean latency to the first generalized 
seizure in KA-treated Otx2flox/flox mice was 18.9 ± 8.7 min (Table 3). Progression of 
clinical signs was dramatically different in En1Cre/+; Otx2flox/flox animals (Figure 22). 
Indeed, the trajectory in behavior score of En1Cre/+; Otx2flox/flox mice differed from that 





Figure 22. Resistance to KA-induced seizures in Otx2 conditional mutant mice is abolished by 5-HT 
depletion. Graph shows the progression of behavioral changes over a 2 hr observation period following 
KA in control and Otx2 conditional mutant mice, with or without pCPA pre-treatment. Genotypes and 
treatments are as indicated. Data are reported as mean seizure scores  ±  SE (n = 10 animals per group). 
**, p < 0.001, post hoc Holm-Sidak test, En1Cre/+; Otx2flox/flox vs. the other three treatment groups. 
 
measures ANOVA, p < 0.001; post hoc Holm-Sidak test, En1Cre/+; Otx2flox/flox vs. 
Otx2flox/flox mice, p < 0.001). The majority of Otx2 conditional mutant mice displayed 
only pre-convulsive behaviors, never showing any sign of generalized seizure activity 
(Figure 22). Only 1 out of 10 En1Cre/+; Otx2flox/flox mice showed forelimb clonus with 
rearing and falling, followed by a single, brief tonic-clonic seizure. In this animal, 
latency to the first generalized seizure was 52 min (Table 3). En1Cre/+; Otx2flox/flox never 
showed any sign of generalized seizure activity also at later times (> 2 hours) after KA 
administration (data not shown). Depletion of endogenous 5-HT by pre-treatment with 
pCPA in Otx2 conditional mutant mice (n = 10) resulted in the occurrence of strong 
KA-induced generalized seizures, as observed in Otx2flox/flox mice (Figure 22). Indeed, 
seizure severity in En1Cre/+; Otx2flox/flox pre-treated with pCPA was significantly 
 50
 
different than that observed in the same mice without pCPA (two-way repeated 
measures ANOVA, p < 0.001; post hoc Holm-Sidak test, En1Cre/+; Otx2flox/flox + pCPA 
vs. En1Cre/+; Otx2flox/flox , p < 0.001; En1Cre/+; Otx2flox/flox + pCPA vs. Otx2flox/flox, p > 
0.05). 
Latency to first generalized seizure in Otx2 conditional mutant mice pre-treated 
with pCPA was comparable to that observed in Otx2flox/flox mice (Table 3). Pre-treatment 
with pCPA in Otx2flox/flox mice (n = 10) resulted in the same severity of KA-induced 
behavioral seizures as observed in Otx2flox/flox mice without pCPA and En1Cre/+; 
Otx2flox/flox mice pre-treated with pCPA (two-way repeated measures ANOVA, p>0.05; 
post hoc Holm-Sidak test, Otx2flox/flox + pCPA vs. Otx2flox/flox or En1Cre/+; Otx2flox/flox + 
pCPA, p > 0.05). Saline-treated animals of all genotypes never showed any sign of 
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25 ± 7.9 
 
32.3 ± 12.7 
     
 
Table 3. Effect of 5-HT depletion on KA seizures in control and Otx2 conditional mutant mice. a 
The number of animals with generalized seizures significantly differed between En1Cre/+; Otx2flox/flox  and 
the other groups (z-test, p < 0.001). b Latency to the 1st generalized seizure is calculated from the time of 
KA administration. Values (min) are reported as mean ± SD. Latency did not differ between  Otx2flox/flox, 
Otx2flox/flox  + pCPA and En1Cre/+; Otx2flox/flox  + pCPA mice (one-way ANOVA, p=0.062).c The value 
reported refers to the only animal that showed a generalized seizure. 
 
 
Expression of c-fos in Otx2 inactivated mice 
We next used c-fos mRNA in situ hybridization to study the pattern of brain 
activation at 2 hr after KA injection. A strong c-fos mRNA labeling was observed in the 
septum, caudate-putamen, cerebral cortex, amygdala, hypothalamus and hippocampus 
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of Otx2flox/flox mice, whereas c-fos mRNA induction was restricted to the hippocampus 
in En1Cre/+; Otx2flox/flox mice (Figure 23). Conversely, En1Cre/+; Otx2flox/flox mice pre-
treated with pCPA showed the same widespread c-fos mRNA labeling, as observed in 
Otx2flox/flox mice. Pre-treatment with pCPA did not alter the pattern of KA-induced c-fos 
mRNA expression in Otx2flox/flox mice (figure 23). Saline-treated animals of both 




Figure 23. Effect of 5-HT depletion on c-fos mRNA expression in the brain of KA-treated control and 
Otx2 conditional mutant mice. Panels show c-fos mRNA in situ hybridizations on coronal sections at the 
level of the caudate-putamen (top) and dorsal hippocampus (bottom) from representative control and 
Otx2 conditional mutant mice (with or without pCPA pre-treatment), 2 hr following KA. Genotypes and 
treatments are as indicated. Abbreviations: amy, amygdala; CPu, caudate-putamen; ctx, cerebral cortex; 
hip, hippocampus; ht, hypothalamus; sept, septum. Scale bar = 2 mm. 
 
 
En1Cre/+; tOtx2ov transgenic mice 
 
KA seizure susceptibility 
Adult En1Cre/+; tOtx2ov mice and control tOtx2ov mice received a single systemic 
injection of KA (20 mg/kg) and seizure susceptibility were observed for 3 hrs.  tOtx2ov 
(n= 5) mice showed pre-convulsive behavior, with head movements, rigid posture and 
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facial automatisms in the first half hour (stage 2). Stage 3-4 behaviours (head bobbing 
followed by isolated limbic motor seizures) appeared after about 60 min following KA 
administration. This condition lasted for about 1.5 hours. During the 3rd hour, the 
animals regained some control and began to recover (Figure 24). KA-induced behaviors 
in En1Cre/+; tOtx2ov mice (n = 8) did not present significant differences compared to 
control animals. Animals showed pre-convulsive behaviors within thirty minutes after 
the injection, followed by a worsening of conditions in 60 minutes (stage 4). During the 
2nd hours animals showed convulsive behaviors and recovered during the 3rd hour 
(Figure 24). 
 
Figure 24. KA seizure susceptibility in Otx2 overexpressing mice. Graph shows the progression of 
behavioral changes over a 3 hr observation period following KA in tOtx2ov (n=5) and En1Cre/+;tOtx2ov 
mice (n=8). Data are reported as mean seizure scores  ±  SE. 
 
Expression of c-fos mRNA in Otx2 over expressing mice 
The expression of c-fos mRNA is used as a "marker" of neuronal activity to identify 
areas involved in epileptic seizures (Willoughby, 1997). The expression of c-fos mRNA 
was analyzed by non-radioactive in situ hybridization on sagittal sections from adult 
brains. In tOtx2ov mice treated with KA (stage 4-6 seizures) c-fos mRNA expression was 
throughout the cortex, striatum, thalamus, hippocampus and the entire cerebellum; 






Figure 25. Expression of c-fos mRNA expression in the brain of KA-treated control and Otx2 
overexpressing mutant mice. The Panels show c-fos mRNA in situ hybridizations on coronal sections at 
the level of the dorsal hippocampus from representative control and Otx2 over-expressing mice, 2 hr 
following KA. Genotypes and treatments are as indicated. Abbreviations: cb, cerebellum; ctx, cerebral 
cortex; DG, dentate gyrus; ht, hypothalamus; thal, thalamus. Scale bar 0.5 cm.  
 
 
Conversely, saline-treated En1Cre/+; tOtx2ov mice showed c-fos mRNA expression at the 
level of temporal cortex, striatum and the thalamus. Interestinglym En1Cre/+; tOtx2ov 
mice treated with KA presented a generally lower c-fos mRNA expression throughout 
the entire brain, with the exception of the CA3 region of the hippocampus (Figure 25). 
 
 
En-1+/-/En-2-/- (EnHT) mutant mice 
 
Seizure susceptibility in EnHT mice.  
Adult EnHT mice and wild type mice (n=8 per genotype) received a single systemic 
injection of KA (20 mg/kg) and were observed for 3 hrs. EnHT mice showed pre-
convulsive behaviors (head bobbing and rigid posture) in the initial 20 min after KA 
administration. Soon after, they reached behavioral seizure score 4-5 (repeated limbic 
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seizures), and this condition lasted for a period of 90 minutes. Progression of clinical 
signs in the wild type mice was little less but not significantly different from what 




Figure 26. Seizure susceptibilityinduced by KA injection. Graph shows the progression of behavioral 
changes over a 3 hr observation period following systemic KA administration (20 mg/kg, i.p.) in wild 
type (n=8) and EnHT mice (n=8). Data are reported as mean seizure scores  ±  SE. 
 
 
Expression of IEG in EnHT mice 
We next used c-fos mRNA in situ hybridization to study the pattern of brain activation 
at 3 hr after KA in WT and EnHT mice. A c-fos mRNA labeling was observed in the 
cerebral cortex, amygdala, thalamus and hippocampus of WT mice, whereas weak c-fos 
mRNA induction was restricted only to the hippocampus (CA3 region) in EnHT mice. 
Saline-treated animals of both genotypes did not show any c-fos mRNA labeling 





Figure 27. Expression of c-fos mRNA expression in the brain of KA-treated control and EnHT mutant 




En2-/- mutant mice 
En2-/- mice display an increased susceptibility to KA seizures. 
En2-/- mice were initially used used as controls for EnHT mice in KA seizure 
susceptibility experiments. Unexpectedly, En2-/- mice showed an increased response to 
KA (20 mg/kg) when compared to WT (Figure 28) as well as EnHT mice (see Figure 
26). In WT, this dose of KA generally resulted in the sole appearance of pre-convulsive 
behaviors at all time-points analyzed (Figure 26 and 28). Only four out of 8 WT mice 
displayed brief, isolated episodes of limbic motor seizures (rearing with forelimb 
clonus, stage 4), and never showed tonic-clonic (stage 6) seizures. The same KA dose 
in En2-/- mice elicited clear signs of focal epilepsy (head bobbing) within the first 20 
min, rapidly culminating in stage 4 limbic motor seizures. Latency to the first stage 4 
seizure did not differ from that observed in WT mice (Table 4). In sharp contrast with 
WT, the majority (7 out of 12) of En2-/- mice displayed severe tonic-clonic seizures 
(Table 4). En2-/- mice showed generalized stage 4-6 seizures for about two hours (40-




Figure 28. Increased susceptibility to KA-induced seizures in En2-/- mice. Progression of behavioral 
changes after systemic KA administration (20 mg/kg, i.p.) in WT and En2-/- over a 3 hr observation 
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35.5 ± 7.7 
 
 
24.7 ± 3.2 b
animals with 






latency (min) to 1st





49.8 ± 13.9 
 
Table 4. Generalized seizures in WT and En2--/- mice.Seizure latency (mean ± SE) is calculated from 
the time of KA administration. a not different between the two groups (z-test, p > 0.05); b not different 
between WT and En2--/- mice (Mann-Withney test, p  > 0.05); * significantly different between the two 
groups (z-test, p < 0.05); n.d., not determined. 
 
ANOVA revealed a significant effect of genotype (F(1,136) = 7.522, p = 0.014). Multiple 
comparison procedure showed that En2-/- mice had significantly higher behavioral 
scores than WT mice at all time points analyzed (Figure 28; Holm-Sidak post-hoc-test, 
WT vs. En2-/- mice, p < 0.05). Saline-injected animals of both genotypes showed no 
sign of epileptic activity during the whole period of observation (not shown). 
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En2-/- mice display increased induction of IEGs after KA seizures. 
c-fos and c-jun mRNA induction was analyzed by in situ hybridization on WT 
and En2-/- brains, 3 hr after KA administration, to map brain areas differentially 
activated by KA in the two genotypes. In WT mice, c-fos mRNA was mainly detected 
in the hippocampus and in other limbic areas (amygdala, pyriform/entorhinal cortex). 
No signal was detected in the caudate-putamen and thalamus (Figure 29A). This 
induction profile was also observed for c-jun mRNA, with the exception of the 
pyriform cortex (that showed no c-jun mRNA labelling) (Figure 29A).  
 
 
Figure 29. IEGs are differentially induced by KA in WT and En2-/- mice. A) c-fos and c-jun mRNA in 
situ hybridizations, 3h after KA. Representative sections at the level of the caudate-putamen and dorsal 
hippocampus are shown. Genotypes and relevant brain areas are as indicated. Abbreviations: amy, 
amygdala; CA1/CA3, pyramidal cell layers of the hippocampus; CPu, caudate-putamen; DG, dentate 
gyrus; ent, entorhinal cortex; ht, hypothalamus; pyr, pyriform cortex; sept, septum; thal, thalamus. 2-3 
and 5-6 indicate layers of the cerebral cortex Scale bar = 2 mm. B,C) Quantification of c-fos (B) and c-
jun (C) mRNAs in parietal/temporal cortex of KA-treated WT and En2-/- mice. Values are mean 
normalized signal intensities ± SE. **, p<0.001 (Student’s t-test). 
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In keeping with seizure generalization observed by behavioral analysis, a widespread 
and strong induction of both c-fos and c-jun mRNAs was detected throughout En2-/- 
brains. In particular, c-fos and c-jun mRNA labelling was evident in caudate-putamen, 
pyriform cortex, thalamus, amygdala, hippocampus, entorhinal cortex and other cortical 
areas (Figure 29A). Quantification of in situ hybridization experiments performed at the 
level of the parietal cortex confirmed that c-fos and c-jun mRNAs were significantly 
increased in both layers 2-3 and 5-6 in En2-/- brains, as compared to WT controls 
(p<0.001, Student’s t-test) (Figure 29B-C) Saline-treated mice of both genotypes did 
not show any c-fos mRNA signal, while basal levels of c-jun mRNA were detected in 
the hippocampus in these animals (not shown). 
 
Long-term histopathology in KA-treated En2-/- mice. 
          In order to assess whether increased susceptibility to KA-induced seizures in 
En2-/- mice also resulted in increased susceptibility to long-term damage, the histology 
of pyramidal cell layers and mossy fiber pathway was evaluated in the hippocampus of 
WT and En2-/- mice, 7 days after KA. Immunostaining for the pan-neuronal marker 
NeuN on brain sections from WT mice did not reveal any damage in the CA1 
pyramidal cell layer (Figure 30), and scattered degenerated cells were only occasionally 
observed in CA3 pyramidal neurons (Table 5). Conversely, in En2-/- mice, cell loss and 
tissue sclerosis were detected in 4 out of 7 animals in both CA1 and CA3 regions 
(Figure 30 and Table 5). 
 
Figure 30. KA-induced neurodegeneration in the CA1 subfield of En2-/- mice. NeuN immunostaining of 
coronal sections from the dorsal hippocampus of WT and En2 -/- mice, 7 days after KA. Abbreviations: 




Histological changes in the mossy fiber pathway were evaluated using 
neuropeptide Y (NPY) immunohistochemistry. A robust up-regulation of NPY 
immunoreactivity was found in the mossy fibers of dentate gyrus in all En2-/- mice 
(Figure 31B), whereas no such labelling was detected in WT animals (Figure 31A). 
Quantification of NPY staining in the mossy fiber pathway from WT and En2-/- mice 
confirmed these findings (Figure 31C). Saline-treated mice of both genotypes did not 
show any sign of hippocampal histopathology (not shown). 
 
 
   
Degree of  cell damage (n. of animals) 
 
 









     
CA1 
WT (n = 5) 













     
CA3 
WT (n = 5) 














Table 5.  Cell damage in hippocampal CA1/CA3 pyramidal layers of KA-treated WT and En2-/- 
mice. Brain damage was evaluated in NeuN-stained sections, 7 days after KA, according to the scale 
described in Experimental Methods. 
 
 
Figure 31. NPY up-regulation in the mossy fiber pathway of KA-treated En2-/- mice. A,B) 
Representative NPY staining in the hippocampus of WT (A) and En2-/- (B) mice, 7 days after KA. The 
almost complete loss of CA1 pyramidal cell layer is also visible in (B). Abbreviations: CA1, pyramidal 
cell layer; h, hilus; mf, mossy fibers. Scale bar: 500 μm. C) Quantification of NPY staining intensity in 
the mossy fibers of WT and En2-/- mice. Each box chart summarizes the distribution of the NPY signal-
to-background ratio (intensity of NPY label divided by the background staining) for all hippocampal 
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sections in each group. The horizontal lines in the box denote the 25th, 50th, and 75th percentile values. 
The error bars denote the 5th and 95th percentile values. **, p < 0.001 (Mann-Whitney rank sum test). 
 
En2 mRNA is expressed in the adult mouse hippocampus and cerebral cortex.  
Neuroanatomical and behavioural studies performed on adult En2-/- mice suggest that 
En2 might be expressed also in anterior brain structures during adulthood (Cheh et al. 
2006; Kuemerle et al. 2007). We therefore investigated En2 mRNA expression in 
different brain areas of the adult mouse brain. To this purpose, we performed 
quantitative real-time RT-PCR experiments using the mitochondrial ribosomal L41 
protein mRNA as a standard for quantification.  
 
 
Figure 32- En2 mRNA is expressed in adult mouse hip and ctx and is regulated by seizure activity. (A, 
B) Real-time RT-PCR amplification profiles of mitochondrial ribosomal protein L41 (A) and En2 (B) 
mRNAs from the cb (blue line), vmb (green line), hip (black line) and ctx (red line) of WT adult mice. 
The graphs report the appearance of fluorescence in PCR amplicons as a function of the number of PCR 
cycles. (C, D) Graphs report the quantification of real-time RT-PCR experiments. In (C), values are 
expressed as En2 mRNA/L41 mRNA comparative quantitation ratios (average values of three technical 
replicates) in different adult brain areas, normalized to cb. In (D), values are expressed as En2 
mRNA/L41 mRNA comparative quantitation ratios (average values of three technical replicates), from 
the hip of KA-treated adult mice (3 h post KA, 20 mg/kg i.p.), normalized to saline-treated controls. 




As expected, L41 amplification gave comparable amplification curves from all brain 
areas analyzed (cere- bellum, ventral midbrain, hippocampus, cerebral cortex; Figure 
32A). En2 transcripts were detected at low but significant levels in the hippocampus and 
cerebral cortex; En2 amplification curves from these two areas were indistinguishable 
(Figure 32B). According to previous studies (Joyner et al. 1991; Millen et al. 1994; 
Simon et al. 2001), En2 mRNA was detected at higher levels in the ventral mid-brain 
and cerebellum (Figure 32B). Comparative quantification of real-time RT-PCR 
experiments showed that in hippocampus and cerebral cortex, En2 mRNA was present 
about 100 times less than in cerebellum (Figure 32C). In the adult hippocampus, En2 
mRNA levels were regulated by pathological hyperactivity. In animals that experienced 
generalized seizures following systemic administration of the glutamate agonist KA (20 
mg/kg i.p.), En2 mRNA levels were decreased by 30%, as compared to saline-treated 
controls (Figure 32D). 
 
En2-/-  mice have a reduced expression of GABAergic markers in the hippocampus, 
cerebral cortex and hilus.  
Since En2 is expressed in the adult hippocampus (Figure 32B, C), we sought to 
investigate the presence of subtle neuro-anatomical defects in this structure of En2-/-  
mice. Immunohistochemistry experiments with anti-parvalbumin and anti-somatostatin 
antibodies were performed to detect selected GABAergic interneuron populations 
(Matyas et al. 2004; Jinno and Kosaka, 2006) in the hippocampus of WT and En2-/-  
mice. In WT mice, parvalbumin revealed the typical staining around the cell bodies of 
pyramidal neurons of CA1 (not shown) and CA3 (Figure 33) hippocampal subfields 
(see also Matyas et al. 2004), whereas somatostatin predominantly labeled stratum 
lacunosum moleculare and hilar interneurons (Fig. 33; see also Matyas et al. 2004). In 
En2-/-  mice, staining for both parvalbumin and somatostatin was markedly reduced in 




Figure 33. Downregulation of GABAergic markers in the hippocampus of En2-/- mice. (A) 
Representative parvalbumin staining in the CA3 pyramidal cell layer of WT and En2-/- mice. (B) 
Representative somatostatin staining in the slm and hilus of WT and En2-/- mice. Abbreviations: gcl, 
granule cell layer; ml, molecular layer; slm, stratum lacunosum moleculare. Scale bar 50 μm. 
 
 
We further investigated the neuroanatomy of GABAergic interneurons in the 
hippocampus and cerebral cortex of adult En2-/- mice by performing 
immunohistochemistry for parvalbumin (PV), NPY and somatostatin (SOM). Adult (6 
months old) En2-/- mice, when compared to their age-matched WT controls, present a 
statistically significant reduction in the number of PV-positive interneurons in layers 2-
3 of the parietal/temporal cortex and in the hilus of the dentate gyrus but no significance 
difference was observed in layers 5-6 of the parietal/temporal cortex (Figure 34). A 
statistically significant reduction in the number of NPY-positive interneurons was also 
detected in the parietal/temporal cortex (layers 2-3 and 5-6) as well as the hilus of En2-/- 
mice, as compared to WT (Figure 34). Similarly, the significant reduction in the number 
of SOM-positive interneurons was observed in En2-/- mice in layers 2-3 of the 
parietal/temporal cortex when compared with the WT animals, but no significance 
difference was observed in layers 5-6 of the parietal/temporal cortex and hilus of the 





Figure 34. Reduction of parvalbumin, NPY and somatostatin positive neurons in the cerebral cortex and 
hilus of En2-/- mice. Top: representative PV, NPY, SOM immunostainings from the parietal/temporal 
cortex of WT and En2-/-  mice. Cortical layers are indicated. Middle: representative PV, NPY, SOM 
positive neurons in the hilus of WT and En2-/- mice. Bottom: quantification of PV, NPY, SOM 
immunohistochemistry data. Data are expressed as the mean number of positive cells per area +/- s.e.m 
(area was 0.06 mm2 for cortical layers and 0.1 mm2 for the hilus). *, p< 0.05;  ***, p< 0.001 (t-test, En2-/- 
























Summary of results 
Our studies, performed on classical and conditional knockout mouse lines, demonstrate 
that altered embryonic development of dopaminergic and serotonergic neurons results 
in altered seizure susceptibility in the adult life. 
 
We investigated seizure susceptibility in the following mutant mice. 
1) Mice with conditional inactivation of the Otx2 gene in DA precursor cells. In these 
mice, Otx2 was conditionally inactivated by a Cre recombinase expressed under the 
transcriptional control of the En1 gene (En1Cre/+; Otx2flox/flox). Severe abnormalities 
were detected in the ventral midbrain, namely extensive reduction and 
disorganisation of DA neurons. This resulted in a neurotransmitter fate switch from 
DA to 5-HT so that these mice had a 70% reduction in the number of DA neurons 
and an increased number of 5-HT neurons in the ventral midbrain, that persisted 
until adult age (Puelles et al. 2004; Borgkvist et al., 2006). In particular, adult 
En1Cre/+;Otx2flox/flox mice showed a massive increase of 5-HT in the pons, ventral 
midbrain, hippocampus (CA3 subfield) and cerebral cortex, that was paralleled by 
reduced levels of 5-HT transporter (Sert) in the same areas. Due to this increased 5-
HT hyper-innervation, En1Cre/+; Otx2flox/flox mice were resistant to generalized 
seizures induced by the glutamate agonist kainic-acid (KA). Brain 5-HT depletion 
by pCPA in conditional mutant mice reduced 5-HT content to control levels in these 
brain areas, fully re-establishing KA-seizure susceptibility, meaning that increased 
brain 5-HT levels were responsible for seizure resistance in Otx2 conditional 
mutants.  
 
2) Mice with conditional over-expression of the Otx2 gene in DA precursor cells. In 
these mice, Otx2 was conditionally overexpressed by a Cre recombinase under the 
transcriptional control of the En1 gene (En1Cre/+; tOtx2ov). Otx2 overexpression 
resulted in a 35% increase of DA progenitors neurons in the VTA of the anterior, 
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and more prominently in posterior mesencephalon (Omodei et al. 2008). It is 
important to point out that, apart from the increased number of DA progenitors, 
these conditional over-expressing mice did not show any alteration in 5-HT neurons. 
The increase in DAergic cell number persisted until adult age. En1Cre/+; tOtx2ov 
mice did not show significantly altered KA induced seizure susceptibility when 
compared to control animals. 
 
3) En1+/-; En2-/- (EnHT) mice, which display a postnatal and progressive loss of DA 
neurons of the substantia nigra. The phenotype of these mutant mice resembles key 
pathological features of Parkinson’s disease. It is important to point out that the 
postnatal DA cell loss in EnHT mice is not accompanied by altered number of 5-HT 
cells. EnHT mice did not show significantly altered KA induced seizure susceptibility 
when compared to control animals. 
 
4) En2-/- mice, which show no alteration in the number of DA and 5-HT neurons at all 
ages, were initially used as a control strain for experiments performed on EnHT mice. 
When we evaluated KA seizure susceptibility in En2-/- mice, we surprisingly and 
unexpectedly found that En2-/- mice have an increased susceptibility to KA-induced 
seizures. En2-/- mice also showed long-term histopathology with marked 
degeneration in CA1 pyramidal neuron and up-regulation of mossy fiber pathway. 
The occurrence of generalized seizures in En2-/- mice was likely due to defects in 
GABAergic innervation onto principal hippocampal neurons and reduced number of 
inhibitory neurons (such as SOM, PV and NPY-positive neurons) in the hilus and 
cortical layers 2-3 and 5-6.  
 
DA, 5-HT and seizure susceptibility 
Systemic KA administration has been widely used to study the susceptibility to acute 
seizures and seizure-induced long-term histopathology in inbred and mutant mouse 
strains. Our studies, carried out in mutant mouse lines with alteration in Otx2 or 
Engrailed1/2 genes, show that altered specification of DA and 5-HT cell fate during 
embryonic development results in altered seizure susceptibility in the adult age. 
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Classical pharmacological studies indicate that both DA and 5-HT may have an anti-
epileptic action.  
          A large series of studies strongly support the idea of an antiepileptic action of 
DA. Indeed, DA agonists inhibit convulsive seizures, both in experimental animals and 
humans. For example, the prototypical mixed D1/D2 receptor stimulant apomorphine 
has long been known to exert an antiepileptic action in humans (Starr, 1996). Indeed the 
neuroprotective role of DA D2 receptors against glutamate-induced excitotoxicity has 
been well described (reviewed in Bozzi and Borrelli, 2006). DA through D2 receptor 
exerts an inhibitory control on the response to seizure promoting stimuli such as KA 
(Bozzi et al. 2000). Mesolimbic DAergic pathways have been proposed to exert this 
inhibitory control (LaGrutta and Sabatino, 1990; Starr, 1996). Similarly, there has been 
increasing evidence that serotonergic neurotransmission modulates a wide variety of 
experimentally induced seizures. Generally, agents that elevate extracellular 5-HT 
levels, such as 5-hydroxytryptophan and serotonin reuptake blockers, inhibit both focal 
and generalized seizures. Conversely, depletion of brain 5-HT lowers the threshold to 
audiogenically, chemically and electrically evoked convulsions (Badgy et al. 2007). 
Furthermore, it has been shown that several anti-epileptic drugs such as valproic acid, 
lamotrigine, carbamazepine, phenytoin, zonisamide elevate and/or stimulate basal 5-HT 
levels and/or release, as part of their anticonvulsant action (Okada et al. 1992; Dailey et 
al. 1996; Ahmad et al. 2005). Moreover, 5-HT receptors are expressed in almost all 
networks involved in epilepsies. These studies indicate that both DA and 5-HT are 
clearly involved in the control of epileptic seizures. According to this view, it was 
expected that reduction of DA cells in both En1Cre/+; Otx2flox/flox and EnHT mice would 
contribute to increase seizure susceptibility in these animals, while increase in DA cells 
in En1Cre/+; tOtx2ov mice would contribute to lower seizure susceptibility severity. On 
the contrary, En1Cre/+; Otx2flox/flox mice were markedly resistant to KA seizures due to 5-
HT hyper-innervation, whereas En1Cre/+; tOtx2ov mice and EnHT mice (in which 5-HT 
levels were unchanged) showed a normal susceptibility to KA induced seizures (Table 
6). This is in line with earlier observation that 5-HT levels are inversely proportional to 
seizure susceptibility. More importantly, altered level of DA in En1Cre/+; Otx2flox/flox, 
En1Cre/+; tOtx2ov and EnHT mice had less impact in altering seizure susceptibility. 
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Indeed En1Cre/+; Otx2flox/flox mice (which have reduced level of DA) did not show 
increased seizure susceptibility, while En1Cre/+; tOtx2ov and EnHT mice (which have 
higher and lower level of DA, respectively, with no alterations in 5-HT), showed 
unaltered seizure threshold. Thus, the altered embryonic development of 5-HT neurons 
seems to have a more prominent effect onto seizure control than the altered 
development of DA neurons (Table 6: Tripathi et al. 2010).  
 
Mouse strain DA and 5-HT alterations KA seizure susceptibility 
En1Cre/+; Otx2flox/flox Less DA, more 5-HT Resistant 
En1Cre/+; tOtx2ov More DA, no difference 5-HT Not altered  
En1+/-; En2-/- (EnHT) Less DA, no difference 5-HT Not altered  
En2-/- No difference DA, 5-HT Increased  
Table 6. The effect of 5-HT hyper-innervation onto seizure control is more prominent than that of DA 
reduction in these animal models. 
 
             The brain areas which are crucially involved in the serotonergic control of 
seizures are the ventral midbrain and limbic system. For example, endogenous 5-HT 
transmission in the substantia nigra is able to inhibit the spread of seizure activity 
generated in the limbic system (Pasini et al. 1996). In En1cre/+; Otx2flox/flox mice, we 
detected increased levels of 5-HT in several brain areas, including the ventral midbrain, 
basal forebrain, cerebral cortex and hippocampal CA3 subfield. Prolonged pre-
treatment of En1cre/+; Otx2flox/flox mice with the 5-HT synthesis inhibitor pCPA restored 
brain 5-HT content to control levels and abolished seizure resistance in mutant mice. 
This indicates that increased availability of synaptic 5-HT is indeed protective against 
KA seizures in En1cre/+; Otx2flox/flox mice. Increased synaptic availability of 5-HT was 
also indicated by decreased SERT levels in the hippocampus and ventral midbrain of 
En1cre/+; Otx2flox/floxmice. Indeed, SERT decrease has been demonstrated to occur after 
prolonged elevation of 5-HT levels in mice (Mirza et al. 2007). Thus, in Otx2 







Impact of genetic background on seizure susceptibility 
It is widely known that the genetic background impacts seizure susceptibility in the 
mouse. Specifically, several studies demonstrate that different inbred mouse strains 
have a different response to KA-induced seizures. For example, DBA/2 mice are 
extremely prone to KA-induced seizures, whereas C57Bl/6 have a relatively lower 
susceptibility when compared to DBA/2 (Ferraro et al. 1995; Schauwecker and 
Steward, 1997). In our study, we used Otx2flox/flox, En1cre/+; Otx2flox/flox, tOtx2ov and 
En1Cre/+; tOtx2ov mice of a mixed DBA/2 x C57BL/6 genetic background, while EnHT, 
En2-/- and WT mice were of a mixed 129/Sv x C57BL/6 genetic background. 
Otx2flox/flox control mice displayed high susceptibility to seizures induced by 20 
mg/kg KA, similarly to what has been observed in DBA/2 mice (Ferraro et al. 1995; 
McLin and Steward, 2006) and mice with a mixed DBA/2 x C57BL/6 background 
(Dell’Agnello et al. 2007). Conversely, En1cre/+; Otx2flox/flox mice showed a marked 
resistance to KA induced seizures, indicating a protective effect of 5-HT in the mixed 
DBA/2 x C57BL/6 background. This also strengthens the idea that the effect of 5-HT 
hyper-innervation onto seizure control is more prominent than that of DA reduction. 
Since En1Cre/+; tOtx2ov mice have a mixed DBA/2 x C57BL/6 genetic 
background, one would have expected higher susceptibility to KA-induced seizures in 
these mice. However,  En1Cre/+; tOtx2ov mice showed moderate susceptibility to seizures 
induced by KA. This can be explained with the fact that conditional overexpessing mice 
have an increased number of DA in VTA but no alteration in 5-HT neurons. Indeed, in 
the experiments with Otx2 conditional mutants we have shown that altered DA levels 
have no impact onto seizure susceptibility. 
           In the experiments with En1+/-; En2-/- (EnHT) and En2-/- mice we used animals of 
amixed 129/Sv x C57BL/6 genetic background. As expected, WT mice of this 
background displayed a very mild response to 20 mg/kg KA, never showing continuous 
generalized epileptic activity (stage 5 seizures) or tonic-clonic seizures (stage 6) after 
KA. The response of EnHT mice to the same KA dose did not differ from that of WT 
controls; this is in keeping with our idea that altered DA cell number has a minimal 
influence onto seizure control. Unexpectedly, En2-/- mice of this background showed 




IEGs study in the different mouse strains 
The striking activation of immediate early genes (IEGs) like c-fos and c-jun expression 
in neurons following seizures (Morgan et al. 1987) led to consider the induction of 
these genes as a marker of neuronal activity in the mammalian nervous system (Sagar et 
al.  1988). A precise correlation exists between the appearance of generalized seizures 
following KA and the pattern of c-fos and c-jun mRNA induction. Pre-convulsive 
behaviors (stages 1-3 of the Racine’s scale) induce c-fos mainly in the hippocampus, 
whereas generalized seizures (stages 4-6) result in a widespread expression in several 
brain areas (Willoughby et al. 1997; Bozzi et al. 2000). Seizure resistance in En1cre/+; 
Otx2flox/flox mice was indeed confirmed by gene expression studies. En1cre/+; Otx2flox/flox 
mice never experienced generalized seizures after KA, showing c-fos mRNA induction 
restricted to the hippocampus. Conversely, En1cre/+; Otx2flox/flox mice pretreated with 
pCPA, as well as Otx2flox/flox mice, showed KA-induced generalized seizures and 
widespread induction of c-fos mRNA from hippocampus to different brain region 
including caudate putamen, septum, cerebral cortex, amygdala and hypothalamus 
(Figure 23; Tripathi et al. 2008). Pre-treatment with pCPA did not alter the pattern of 
KA-induced c-fos mRNA expression in Otx2flox/flox mice. 
Mild susceptibility to KA seizures in tOtx2ov control mice correlated with 
moderate to high c-fos mRNA expression in temporal and parietal cortex, thalamus, 
hippocampus and cerebellum. Conversely, conditional overexpression of Otx2 in  
En1Cre/+; tOtx2ov mice resulted in a reduced expression of c-fos mRNA in these brain 
regions following KA treatment. This suggests that the incresased VTA cell number 
(and, likely, increased DA projections to the limbic system) has an inhibitory effect 
onto KA-dependent c-fos mRNA expression in En1Cre/+; tOtx2ov mice. These data 
definitely need further investigation. 
EnHT mice have a moderate KA seizure susceptibility and show a weak c-fos 
mRNA induction restricted only to the hippocampus (mainly in the CA3 region). It is 
interesting to note that apart from the reduced number of DA neuron, EnHT mice have 
lower levels of the dopamine transporter (DAT) (Paola Sgadò, personal 
communication) meaning that synaptic DA level might not be significantly less or 
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different than control animals. This might explain the unaltered seizure susceptibility 
observed in these mice (Figure 26). Indeed DAT may play an important role in 
modulating gene expression and contributing to neuroadaptive processes within 
dopamine neurons. The DAT substrates dopamine and amphetamine robustly induced 
c-fos expression in hDAT cells but not in wild-type HEK-293 cells, demonstrating that 
that dopamine can induce c-fos expression in a DAT-dependent manner (Yatin et al. 
2002). In accordance with this, lower level of DAT might contribute also in reduced c-
fos mRNA expression in EnHT mice. 
En2-/- mice showed long-lasting generalized seizures and widespread induction 
of IEGs like c-fos and c-jun mRNA in caudate-putamen, pyriform cortex, thalamus, 
amygdala, hippocampus, entorhinal cortex and layer 2-3 and layer 5-6 of cortical areas. 
As expected, WT C57BL/6 mice experienced no or very brief generalized seizures after 
KA, showing IEGs mRNA induction restricted to the hippocampus and other limbic 
areas (Figure 29; Tripathi et al. 2009). 
 
Long-term damage  
In order to assess whether increased susceptibility to KA-induced seizures in En2-/- 
mice also resulted in increased susceptibility to long-term damage, the histology of 
pyramidal cell layers was evaluated in the hippocampus of WT and En2-/- mice, 7 days 
after KA. It is well known that CA1 and CA3 pyramidal neurons are the most 
vulnerable to the excitatory and neurotoxic effects of KA (Ben-Ari, 1985) because of 
the high density of KA binding sites in this terminal field of the hippocampal mossy 
fibre system (Berger and Ben-Ari, 1983). Indeed, CA1 pyramidal cells of KA-treated 
rats show increased N-methyl-D-aspartate (NMDA) excitatory postsynaptic responses 
(Turner and Wheal 1991; Williams et al. 1993) while GABA mediated inhibitory 
synaptic responses are diminished in CA1 pyramidal cells of KA-treated rats (Ashwood 
et al. 1986; Franck and Schwartzkroin 1985; Franck et al. 1988). Generally, mouse 
strains derived from the C57BL/6 strain show minimal cell death in pyramidal 
hippocampal neuron and are resistant to mossy fibre sprouting (McLin and Steward, 
2006). In keeping with these findings, our WT mice never showed cell damage in the 
CA1 pyramidal layer and only occasionally presented little or mild damage in the CA3. 
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A marked degeneration was instead observed in all En2-/- mice analyzed in the CA1 
and, to a lesser extent, in the CA3. The variability in the degree of brain damage 
following systemic KA administration that we observed in WT and En2-/- mice is in 
agreement with previous studies (Schauwecker and Steward, 1997; Bozzi et al. 2000; 
McLin and Steward, 2006). NPY is particularly abundant in the dentate gyrus. In this 
region, it is normally expressed mainly by a subset of hilar GABA neurons. It is 
believed that mossy fibre sprouting after KA-induced seizures occurs in response to the 
denervation of the inner molecular layer as a result of the death of neurons in the hilus 
of the dentate gyrus (Cantallops & Routtenberg, 2000). For this purpose, we studied 
NPY up-regulation in the mossy fiber pathway (dentate gyrus to CA3). Importantly, 
En2-/- but not WT mice treated with KA displayed NPY up-regulation in the mossy 
fiber pathway. This pattern of NPY up-regulation is generally considered a reliable 
marker of long-term, post-seizure synaptic rearrangements, and is thought to be 
indicative of an acquired hyper-excitability of the hippocampus following seizures 
(Morimoto et al. 2004; Nadler et al. 2007; Dudek and Sutula, 2007; Sperk et al. 2007; 
Sutula and Dudek, 2007). Moreover, as observed for pyramidal cell loss, 
rearrangements in mossy fibers do not occur following KA in mouse strains derived 
from C57BL/6 (Schauwecker et al. 2000). Our data suggest that inactivation of the En2 
gene also results in long-term anatomical modifications and, likely, hyper-excitability 
of hippocampal circuitry in response to KA seizures. 
 
Seizure susceptibility in En2-/- mice: the role of GABAergic inhibitory system 
En2-/- mice showed increased seizure severity in response to KA. Importantly, 
spontaneous seizures never occurred in naive En2-/- mice (data not shown), indicating 
that increased susceptibility of En2-/- mice is evident only in response to a potent 
seizure-promoting stimulus, such as KA. We investigated whether this increased 
response to KA might be due to altered anatomy of inhibitory GABAergic neurons in 
the hippocampus and cerebral cortex. 
             Changes in GABAergic inhibition in the hippocampus have been examined in 
many experimental models of epilepsy. In general, inhibitory cell loss in epileptogenic 
zones correlates with the induction of seizures, and results in the decrease in synaptic 
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inhibition in pyramidal neurons (Bekenstein and Lothman 1993; Sloviter 1987). 
Moreover, a reduced number of GABAergic neurons in epileptogenic areas is a likely 
cause of hyper-excitability. For this reason, we studied the anatomy of different 
subpopulations of GABAergic neurons (SOM-, PV- and NPY-positive) in the cerebral 
cortex and hippocampus of En2-/- mice. We observed a reduced staining of all these 
inhibitory markers in the cerebral cortex (layers 2-3) and hippocampus of En2-/- mice, 
that might explain the hyper-excitability observed in these mutants. 
 It remains to be determined how the En2 mutation can impact hippocampal 
excitability, a point that was not addressed by our study. Indeed, the En2 gene is 
commonly known for its crucial role in pattern formation of the midbrain and hindbrain 
regions. Perhaps due to the more posterior location of engrailed expression, none of the 
alteration in telencephalic structures has been analyzed in either engrailed mutant. 
However, novel evidence suggests that En2 might be implicated also in the 
development of more anterior telencephalic structures. Kuemerle and coworkers 
recently reported distinct anterior shift in the position of the amygdala in the cerebral 
cortex of En2-/- mice. Specifically, it was found that in En2 mice the lateral, basolateral, 
central and medial nuclei of the amygdala are located in approximately 500 um to a 
more anterior position in the cortex when compared to controls (Kuemerle et al., 2007). 
This parallel anterior shift of all four of the nuclei indicates that a noteworthy 
amygdaloid defect is present in the En2 mice. Interestingly, Miyazaki et al. have 
reported a more caudal (posterior) shift in the location of 5-HT immunostained cells in 
the dorsal raphe nucleus of postnatal day 50 rats that were exposed to thalidomide or 
valoproic acid during early embryogenesis. The authors surmise that the locational shift 
of the 5-HT cells is most likely the result of aberrant neuronal migration early in 
development (Miyazaki et al. 2005). It might be possible that something similar could 
be happening in the En2 mutant. With these studies, it seems apparent that the 
organization of the CNS places a high premium on developing a proper balance among 
its many components (Kuemerle et al. 2007). These anatomical alterations might 
impact circuitry and excitability of the amygdala and other limbic structures in En2-/- 
mice. En2 secretion from posterior structures to anterior target areas could explain these 
effects. Indeed, En-2 may also have a role in cell–cell communication, as suggested by 
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the presence of other domains involved in nuclear export, secretion and internalization 
(Joliot et al. 1998; Brunet et al. 2005; Sonnier et al. 2007). Further studies might be 
aimed at determining whether En2 released from ventral midbrain projections can 
influence excitability of more anterior limbic structures such as hippocampus. Our data 
show that in the adult mouse brain, En2 is also expressed in the hippocampus and 
cerebral cortex, two regions crucially involved in seizure generation and spread. These 
results confirm and expand non-quantitative RT- PCR expression data previously 
published online in the Mouse Genome Informatics (MGI) database 
(http://www.informatics.jax.org). 
 
Engrailed-2 and Autism Spectrum Disorders (ASD) 
             The autism spectrum disorder (ASD) is among the most devastating disorders 
of childhood, afflicting up to 13 out of every 10,000 individuals (Fombonne et al. 
2005). ASD comprises several different disorders as defined by deficits in social 
behaviors and interactions. These deficits prevent the development of normal 
interpersonal relationships features that typify the broad range of autistic behavior 
include language impairments (including deficits in verbal and non-verbal 
communication), restricted patterns of interests and activities, abnormal responses to 
sensory stimuli, poor eye contact, an insistence on sameness, an unusual capacity for 
rote memorization, and often repetitive actions (Kemper et al. 1998). Although the 
neuroanatomical basis of autism is still somewhat unclear, certain brain regions appear 
to be regularly altered in individuals with ASD. These include areas in the neocortex, 
cerebellum, amygdala, hippocampus and brain stem (Bauman 1991; Bauman et al. 
1985; Courchesne 1995). It is believed that there are a half dozen or more genes 
remaining to be discovered, three genes that are emerging as plausible players in the 
etiology of ASD are reelin (RELN), the serotonin transporter gene (5-HTT), and En2 
(Bartlett et al. 2005). 
            Due to their complex neurodevelopmental, neuroanatomical and behavioral 
phenotype, En2-/- mice have been proposed as a novel model for autism spectrum 
disorder (ASD). Indeed, abnormalities observed in En2-/- mice resemble – at least in 
part – some of those that have been reported in ASD patients, such as hypoplasia of 
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cerebellar vermal lobules (Courchesne et al. 1988) and subtle but reproducible 
disruption in the anterior/posterior pattern of cerebellar foliation and transgene 
expression, particularly in posterior vermis (Joyner et al. 1991; Millen et al. 1994). 
Many studies also reported a significant reduction in Purkinje cell number, cerebellar 
nuclei and inferior olive in ASD individuals (Williams et al. 1980; Bauman and 
Kemper, 1985; Bauman, 1991; reviewed in DiCicco-Bloom et al., 2006), as also 
observed in En2-/- mice (Kuemerle et al. 1997), as well as “autistic-like” behaviours, 
such as decreased attitude to play, reduced aggressiveness and special learning deficits. 
The cerebellum of En2-/- mice is about one-third smaller than its wild type counterpart 
and harbors subtle abnormalities in its folial pattern. Cell counts reveal that all the 
major cell types of the olivocerebellar circuit (Purkinje, granule, inferior olive and deep 
nuclear) are reduced by 30–40% in the En2-/- mice (Kuemerle et al. 1997). Although 
the structural and cellular changes in the En2-/- cerebellum are not completely 
congruent with those reported in the autistic brain, they are still quite analogous. At a 
functional level, Pierce and Courchesne (2001) provide insight as to how cerebellar 
abnormalities may be linked with autistic behavior.  
                More recently, altered anatomical structure of the amygdala has also been 
reported in En2-/- mice. In these mice, there is an anterior shift of lateral, basolateral, 
central and medial amygdalar nuclei reside in the cortex (Kuemerle et al. 2007). It is 
interesting to notice that in ASD patients, significant neuropathological alterations have 
been described in several telencephalic structures, including the amygdala, 
hippocampus, entorhinal cortex and other limbic areas have shown small cell size and 
increased cell packing density at all ages (reviewed in Palmen et al. 2004; Bauman and 
Kemper 2005; DiCicco-Bloom et al. 2006). Finally, the human EN2 gene maps to 
7q36, a chromosomal region that has been linked to ASD, and two single-nucleotide 
polymorphisms (SNPs) rs1861972 and rs1861973, in the EN2 gene have been 
associated to ASD (Gharani et al. 2004; Benayed et al. 2005; Brune et al. 2008, 
Benayed 2009). 
 
A focal brain pathology that affects frontal or mesiotemporal structures (limbic system) 
can be at the origin of an autistic phenotype as well as the trigger of an epilepsy that 
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aggravates the autistic symptoms. Epilepsy and epileptic process occurring in early 
development interferes with the developing function of specific brain networks 
involved in communication and social behavior (Deonna and Roulet, 2006). Our results 
showed that En2-/- mice have an increased susceptibility to seizures evoked by KA 
(Tripathi et al. 2009). This is in agreement with the high prevalence of epilepsy 
described in ASD patients (Canitano, 2007). Moreover, En2-/- mice display a series of 
neuroanatomical alterations (i.e., reduced expression of GABAergic markers in the 
hippocampus) that might underlie increased excitability in these mutants (Figure 33, 34 
and Tripathi et al. 2009). These data, along with recent findings from other authors 
(Kuemerle et al. 2007), suggests that En2 is implicated also in the development of 
telencephalic structures. Kuemerle and coworkers reported an anterior shift of the 
amygdala in En2 mice. Specifically, it was found that in mutant mice the lateral, 
basolateral, central and medial nuclei of the amygdala are located in a more anterior 
position in the cortex when compared to controls (Kuemerle et al. 2007). Taken 
together, all these studies suggest that En2-/- mice are a suitable model for investigating 
the neurodevelopmental bases of ASD. It remains to be determined how the En2 
mutation can impact hippocampal excitability, and more generally, the structure and 
function of the forebrain. Indeed, the En2 gene is commonly known for its crucial role 
in pattern formation of the midbrain and hindbrain regions. We will further investigate 
the effect of En2 inactivation on the development of forebrain areas and their function 
in the adult brain, with particular attention to those neurodevelopmental, 
neuroanatomical and neurochemical features that are important for ASD. In addition, 
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LIST OF ABBREVIATIONS 
 
 
5-HT                                              5-hydroxytryptamine, 
6-OHDA                                        6-Hydroxydopamine  
8-OH-DPAT                                  8-hydroxy-2-(di-n-propyl amino)tetralin 
A/P                                                 Antero-posterior  
ADHD                                           Attention-deficit–hyperactivity disorder  
Amy                                               Amygdala  
Bf                                                  Basal forebrain  
cc                                                  Corpus callosum  
CNS                                              Central Nervous System  
Cpu                                               Caudate-putamen 
Ctx                                                Cerebral cortex  
D/V                                               Dorso-ventral  
DA                                                Dopamine 
DAT                                              Dopamine transporter, 
DG                                               Dentate gyrus  
Di                                                 Diencephalons  
DRN                                             Dorsal Raphe Nucleus 
En                                                Engrailed  
Ent                                               Entorhinal cortex  
ES  cell                                        Embryonic stem cell 
FP                                               Floorplate 
Fgf8                                            Ffibroblast growth factor 8 
GABA                                         Gamma-aminobutyric acid 
Gbx                                             Gastrulation brain homeobox  
GPCR                                         G protein-coupled receptors 
Hip                                             Hippocampus  
HPLC                                         High performance liquid chromatography  
HT                                              Hypothalamus  
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IEG                                             Immediate early gene  
IHC                                             Immunohistochemistry 
ISH                                              In situ hybridization  
KA                                               Kainic acid  
LGIC                                           Ligand-gated ion channel 
Lmx                                             LIM homeobox transcription factor  
MAO                                           Monoamine Oxidase  
mDA                                            Mesencephalic dopamine  
MHB                                           Mid-hindbrain boundary  
MPTP                                         1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine 
Mrp                                             Mitochondrial ribosomal protein 
Ms                                               Mesencephalon  
Msx                                             Msh homeobox  
Mt                                               Metencephalon  
nAcb                                           Nucleus accumbens  
NeuN                                          Neuronal Nuclei 
NPY                                            Neuropeptide Y  
Ngn                                             Neurogenin  
Nurr                                            Nuclear receptor-related 1 
OM                                             Oculomotor  
Otx                                             Orthodenticle homologue  
P                                                 Prosencephalon  
Pax                                             Paired box  
pCA                                             para-chloroamphetamine 
pCPA                                          para-chlorophenilalanine  
PCR                                            Polymerase Chain reaction 
Pet                                              Plasmacytoma expressed transcript 1  
Pitx                                             Paired-like homeodomain transcription factor 3  
PV                                              Parvalbumin 




r                                                Rhombomeres  
RN                                            Red nucleus  
SE                                             Standard error  
Sept                                           Septum  
SERT                                        Serotonin transporter 
SD                                            Standard deviation 
Shh                                           Sonic hedgehog homolog  
SN                                            Substantia nigra 
SOM                                        Somatostatin 
SSRI                                         Selective serotonin reuptake inhibitors 
TCA                                          Tricyclic antidepressants  
Th                                             Tyrosine hydroxylase  
Thal                                          Thalamus 
TPH                                         Tryptophan hydroxylase        
VMB                                        Ventral midbrain  
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The embryonic development of the Central Nervous System (CNS) requires an 
orchestrated series of events tightly regulating the patterning and regionalization of the 
neural tube, as well as the proliferation, survival and differentiation of distinct neuronal 
populations. All these events are controlled by cascades of activation of transcription 
factors that regulate the expression of specific subsets of genes in restricted regions and 
neuronal populations of the developing CNS. Among these transcription factors, 
homeobox-containing proteins play a crucial role, and altered expression of these 
factors can impact embryonic as well as adult CNS functions. In particular, homeobox-
containing genes have been described to crucially regulate differentiation of 
dopaminergic and serotonergic neurons during brain development. Dopaminergic and 
serotonergic neurons, respectively located in midbrain and hindbrain regions, diffusely 
innervate several forebrain areas, contributing to regulate several physiological 
functions including brain excitability. Classical pharmacological studies clearly showed 
that both dopamine and serotonin markedly regulate seizure susceptibility through 
specific receptor pathways. Our recent studies, performed on classical and conditional 
knockout mouse lines, demonstrate that altered embryonic development of 
dopaminergic and serotonergic neurons results in altered seizure susceptibility in the 
adult life. Here we will review our major findings, in light of other studies recently 










Epilepsy is one of the most common neurological disorders, affecting about 1% of 
human population worldwide. The disease is characterized by the repeated occurrence 
of sudden, transitory and localized bursts of electrical activity, known as seizures. 
Seizures may arise in both cortical and subcortical areas, and depending on the brain 
area that is affected may result in episodes of motor, sensory, autonomic and psychic 
origin. Genetic, traumatic and developmental factors have been clearly implicated in the 
genesis of epilepsy. 
 
The developmental bases of epilepsy are largely unknown. Altered function of genes 
controlling specification of brain areas, neuronal identity and circuit formation may 
certainly lead to altered seizure susceptibility and epilepsy. For example, abnormal 
expression and function of genes involved in brain development might lead to altered 
differentiation of selected neuronal populations and improper shaping of neuronal 






A vast series of clinical and experimental studies clearly demonstrate that all major 
neurotransmitter systems are involved in epileptogenesis, including dopamine (DA) and 
serotonin (5-hydroxytryptamine, 5-HT) [1, 2]. Classical pharmacological studies clearly 
showed that both DA and 5-HT may have potent anti-convulsant effects, acting through 
specific receptor pathways. However, little is known about the impact of an altered 
embryonic development of dopaminergic and serotonergic neurons onto seizure 
susceptibility in the adult life. Here we will review our recent findings resulting from 
the study of classical and conditional knockout mouse lines with an altered 
development of DA and 5-HT systems. 
 
 
ROLE OF DA AND 5-HT IN EPILEPSY 
 
The role of DA and 5-HT in the genesis and control of seizures has been extensively 
reviewed in previous studies [1-4], to which the reader is referred for a detailed 
description of the experimental data. Here we will briefly summarize the major findings 
in this field. 
 
DA and epilepsy. DA has long been postulated to have an anti-epileptic action. The 
anti-convulsant properties of apomorphine (a prototypic DA agonist) were first 
described more than one century ago. Seizure inhibition has been also observed in 
patients administered amphetamines or antiparkinsonian drugs such as pergolide and 
bromocriptine, which all stimulate dopaminergic transmission [2].  
 
The use of dopaminergic ligands specific for the different subclasses of DA receptors 
allowed to demonstrate that DA has an anti-epileptic action also in a wide variety of 
animal models [2, 5]. In particular, these studies illustrated the opposite actions of D1-
like and D2-like receptors in the regulation of seizure activity. The physiological 
balance of DA activity at these two different receptors would be crucial for determining 
the response to seizure-promoting stimuli: activation of D1-like receptors is generally 
pro-convulsant, whereas D2-like receptor stimulation can block seizures. More 
recently, studies performed on different dopamine receptor knockout mouse lines 
confirmed these findings [3, 6-8]. The limbic system is crucially involved in the 
dopaminergic control of epileptic seizures. Indeed, limbic areas of the brain receive 
dopaminergic innervation [9] and express different types of DA receptors [10].  
 
5-HT and epilepsy. The idea that there may be a link between 5-HT and seizure 
inhibition was first suggested as early as 1957 [11]. In this study, a series of 
anticonvulsants, including phenytoin, were shown to elevate brain 5-HT levels. In 
recent years, there has been increasing evidence that serotonergic neurotransmission 
can modulate seizures in a wide variety of experimental models. It is now generally 
accepted that drugs elevating extracellular 5-HT levels (such as 5-hydroxytryptophan or 
selective serotonin reuptake inhibitors, SSRI) exert a powerful antiepileptic action 
against both focal (limbic) and generalized seizures [12-14]. The anticonvulsant effect 
of the SSRI fluoxetine has been clearly demonstrated in a wide variety of 
experimentally induced seizure models, as well as in genetically epileptic animals. 
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Conversely, depletion of brain 5-HT by para-chloroamphetamine (PCA, a selective 
neurotoxin for 5-HT neurons) or para-chlorophenilalanine (pCPA, an inhibitor of 5-HT 
synthesis) can lower seizure threshold, increasing the severity of limbic status 
epilepticus [1, 15]. 
 
Fourteen mammalian 5-HT receptor subtypes are currently recognized, and these have 
been classified into seven receptor families on the basis of their structural, functional 
and, to some extent, pharmacological characteristics [16, 17]. Among these receptors, 
the 5-HT1A, 5-HT2C, 5-HT3 and 5-HT7   subtypes, which are all expressed in 
epileptogenic brain areas (mainly, cerebral cortex and/or hippocampus), are the most 
relevant in epilepsy [1]. For example, administration of 8-hydroxy-2-(di-n-
propylamino) tetralin (8-OH-DPAT, a specific 5-HT1A agonist) is able to reduce 
experimentally induced seizures in rats [18], whereas increased lethality after seizures 
is observed in mice with targeted inactivation of the 5-HT1A gene [19]. Mice lacking 5- 
HT2C receptors also develop epilepsy [20, 21]. 
 
Taken together, all these studies clearly demonstrate that pharmacological and genetic 
manipulation of DA and 5-HT levels can markedly affect seizure origin and spread; 
conversely, little is known about the impact of an altered embryonic development of 
DA and 5-HT neurons onto seizure susceptibility in the adult life. In the following 
paragraph, we will briefly review the genetic networks regulating the differentiation of 
DA and 5-HT neurons during embryonic brain development. We will then summarize 
our recent findings supporting the idea that an altered maturation of these two 
neurotransmitter pathways can markedly affect seizure susceptibility in the adult brain. 
 
 
DEVELOPMENT OF DOPAMINERGIC AND SEROTONERGIC NEURONS 
 
In the mammalian nervous system individual population of neurons develop in a 
stereotypic position identified by their coordinates along the antero-posterior and dorso-
ventral axes [22, 23]. Three organizing centers, the mid-hindbrain boundary (MHB or 
isthmus), the floorplate (FP), and the anterior neural ridge (ANR) control 
regionalization of the two main axes and specify the location and the cell fate of 
specific neuronal population within the brain fate map [24].  This is also true for 
dopaminergic (DA) and serotonergic (5-HT) neurons localized in caudal midbrain and 
rostral hindbrain, respectively [22]. 
 
Regionalization of midbrain/hindbrain territory. The MHB is anatomically 
characterized as a constriction between midbrain and hindbrain, although its precise 
anatomical boundaries have not yet been determined. For this reason the borders of the 
MHB are only defined with the use of expression patterns of specific genes, which 
delineate its competence territory (Figure 1). By embryonic stage 7.5 (E7.5) in mouse, 
the transcription factors Otx2 and Gbx2 are expressed in a complementary fashion in 
the embryo: the border along their expression territories delineates the future junction 
between mesencephalon and metencephalon: the MHB (Figure 1). At early stages Fgf8, 
Wnt1 and Otx2 are expressed in the caudal midbrain regions that give rise to midbrain 
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DA neurons. In contrast, Fgf8 and Gbx2, but not Wnt1, are expressed in the region that 
gives rise to rostral 5-HT progenitors (Figure 1). The transcription factors Engrailed1 
(En1) and Engrailed2 (En2) are instead expressed in both caudal midbrain and anterior 
hindbrain. The expression domain of each gene reflects the role the gene plays in the 
formation of this territory. Otx2 and Gbx2 expression domains are restricted to the 
anterior and posterior part of the neural tube and, by doing so, define positioning of 
MHB along the anterior-posterior axis; Wnt1 and Fgf8 expression patterns are restricted 
to the mid-hindbrain junction in specular domains and are involved in the growth and 
maintenance of MHB cells; genes expressed across the entire mid- and hindbrain 
territory, such as Pax2, Pax5, En1/2, define the identity of this region, as a whole [25-
27]. The second organizing center of the midbrain/hindbrain region is the FP. Sonic 
hedgehog (Shh), the key-signaling molecule of the FP, is mainly supplied to the neural 
tube by the ventral midline structures. During neurogenesis, dopaminergic and 
serotonergic neuron progenitors within the neuroepithelium are committed by the 
combined action of Fgf8 and Shh, originating form the MHB and the FP, respectively.  
 
Determination and differentiation of dopaminergic and serotonergic progenitors. The 
concomitant action of MHB and FP activates in the midbrain a combination of 
transcription factors including Otx2, Lmx1a/b, En1/2, Msx1/2, Ngn2 and Mash1, in a 
temporal sequence. The expression of Otx2, Lmx1b and En1/2 genes is already initiated 
by E9.0 [28-31]. Subsequently, Lmx1a and Msx1/2 expression turns on around E9.5, 
while Ngn2 and Mash1 are not expressed until E10.75 [32]. While Otx2 and En1/2 
participate to the positioning of the MHB region, recent studies identified Lmx1a and 
Msx1 as determinants of midbrain DA neurons [33]. The two transcription factors are 
induced by Shh, either directly or through an unknown signal, in ventral midline cells in 
the mesencephalon. However at least in the intermediate and posterior ventral midbrain 
activation of Lmx1a and Msx1/2 appears to depend on the presence of Otx2 [34], 
suggesting that Otx2 might be required for direct activation of Lmx1a and Msx1/2 
and/or to provide DA progenitors with competence in responding to the Shh by 
inducing the expression of Lmx1a and Msx1/2. Furthermore, while Lmx1a is sufficient 
to induce DA cell differentiation in ventral progenitors cells and induces the expression 
of Msx1/2, Msx1/2 seem to be instead involved in the repression on the lateral 
progenitors cell fate. Floor plate (Shh-positive) cells can turn into dopaminergic 
progenitors through the acquisition of neuronal potential and down-regulation of Shh, a 
step that involves the activation of the proneural genes Ngn2 and Mash1 by the 
combined action of Lmx1a and Msx1/2 [33, 35].  
 
Recent reports have suggested that mesencephalic floor plate cells have indeed the 
potential to directly generate mesencephalic dopaminergic neurons whose A-P identity 
depend on the expression of Otx2 [36]. Despite several reports demonstrate an early 
requirement for Shh, supporting DA progenitors through the induction of Lmx1a, recent 
evidence indicate an additional, later role of Shh to inhibit midline (DA) progenitors 
proliferation and neurogenesis [37]. In this context Wnt1 might have a relevant role in 
regulating cell proliferation. This is supported by the finding that mouse mutants 
lacking or over-expressing Otx2 respectively exhibit loss or increase in both Wnt1 
expression and proliferating activity [34, 38]. Midbrain DA neurons would be therefore 
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specified dorso-ventrally as FP cells and antero-posteriorly by Otx2 signals while 
hindbrain neurons, such a 5-HT cells, would originate from precursors lacking the Otx2 
signal [36, 39]. 
 
A number of genes important for final differentiation and long-term maintenance of DA 
neurons start to be expressed in immature DA neurons including the homeobox genes 
Lmx1b, Pitx3 and En1/2 and the nuclear orphan hormone receptor Nurr1. Loss of 
function of these genes results in the loss of dopaminergic neurons after birth [30, 40, 
41]. During maturation of DA neurons, other genes necessary for the synthesis and 
homeostasis of DA are expressed including, tyrosine hydroxylase (Th), aromatic 
amino-acid decarboxylase (Aadc), vescicular monoamine transporter 2 (Vmat2), 
dopamine D2 receptor (D2r) and dopamine transporter (Dat) as well as other genes 
including c-ret and glial cell-line derived neurotrophic factor receptor α-1 (Gdnfrα-1), 
the receptor complex for the neurotrophic factor glial cell line-derived neurotrophic 
factor (Gdnf). 
 
Rostral hindbrain 5-HT neurons, like midbrain DA neurons, have been shown to 
depend on both the activity of the MHB and the FP. However a third signal, Fgf4, 
coming from the primitive streak, participate to the specification of hindbrain 5-HT 
progenitors. Expression of Nkx2.2 is then essential for specification of 5-HT neurons 
and ventral progenitor identity, conferring competence to become 5-HT neurons [42, 
43]. Nkx2.2 is a homeodomain transcription factor expressed in the ventral-most 
neuroepithelium in response to Shh signaling. Once the position of the precursors is 
defined, other transcription factors are required to establish the serotonergic phenotype. 
These transcription factors are expressed in postmitotic cells, and comprise a Lim 
homeodomain gene Lmx1b, and a transcription factor Pet1. Pet1 has a unique 
expression pattern: it is strictly limited to the raphe nuclei, and appears one day before 
the serotonergic neurons can be identified. This factor could directly activate the 
transcription of the genes that define the 5-HT phenotype: tryptophan hydroxylase 
(Tph), aromatic amino acid decarboxylase (Aadc), the 5-HT transporter (Sert) and the 
vesicular monoamine transporter (Vmat) [43]. 
 
The MHB organizer not only determines the competence of the territory to develop 
certain neuronal populations (dopaminergic and serotonergic), but also defines the 
compartments where progenitor cells are to be positioned along the anterior-posterior 
and dorso-ventral axes. Changing position and extension of the MHB territory, by 
shifting Otx2 or Gbx2 expression domains, can either expand or reduce the DA or 5-HT 
neuron population [39, 44-46]. Furthermore, Otx2 has been shown to be required for 
midbrain DA neuron generation independently of controlling isthmic organizer 
positioning, suggesting that Otx2 may determine the A-P identity of neural progenitors 
that confer DA neuron identity [39, 47].  In particular, manipulations of Otx2 
expression domain result in anterior to posterior (En1Cre/+; Otx2flox/flox mice; [39]) or 
dorsal to ventral (Otx1Cre/+; Otx2flox/flox mice; [46]) transformation of the cell fate with 
the consequent alteration of positioning and extension of DA and 5-HT neuronal 
population. Figure 1 summarizes the genetic networks controlling the differentiation of 





Figure 1. Gene regulatory networks involved in DA and 5-HT neuron differentiation. 
(Top) Patterning signals in the developing brain. Sagittal view of an E11 mouse embryo neural 
tube; anterior is on the left. Expression of the secreted factors fibroblast growth factor 8 (Fgf8), 
Wnt1 and sonic hedgehog (Shh) is depicted at the MHB, in the anterior neural ridge and ventral 
diencephalon and within the floor/basal plate of the spinal cord, hindbrain, midbrain and caudal 
forebrain. Mesencephalic dopaminergic (DA) neurons are induced by a combination of Fgf8 and 
Shh (arrows). 5-HT neurons are specified by a combination of the same factors but they require 
an early inductive signal (Fgf4, not shown) derived from the anterior mesoderm during 
gastrulation. 
(Bottom) Gene expression patterns participating to DA and 5-HT neuron differentiation; anterior 
is on the left. Gbx2 expression maintains Fgf8 expression, whereas Otx2 and Gbx2/Fgf8 
regulate each other negatively. Concomitantly, the expression territories of Fgf8, Wnt1, 
Engrailed and Pax genes become interdependent and establish a positive regulatory loop that 
is necessary to maintain MHB identity. The mid-diencephalic border is positioned by negative 
cross-regulations of Engrailed/Pax and Pax6 (not shown), whereas Fgf8 exerts a negative 
influence on the caudal expression of Hox genes (not shown). Later on, Shh induces the 
expression of Lmx1a and Msx1/2. While Lmx1a is sufficient to induce DA cell differentiation of 
ventral progenitors cells and induces the expression of Msx1/2, Msx1/2 is involved in the 
repression on the lateral progenitors cell fate (not shown). Midbrain DA neurons are specified 
dorso-ventrally by Shh signaling and antero-posteriorly by Otx2 signals, while 5-HT cells 
originate from precursors lacking the Otx2 signal. Shh signaling induces the expression of 
Nkx2.2, which is then essential for specification of 5-HT neurons and ventral progenitor identity, 
conferring competence to become 5-HT neurons. Once positioning and identity of the neuronal 
precursors are determined, specific differentiation programs are activated in DA (Lmx1b, Pitx3, 
Nurr1) and 5-HT neurons (Lmx1b and Pet-1). Adapted from [50, 51]. See text for details. 




ALTERED DEVELOPMENT OF DA AND 5-HT NEURONS CAN AFFECT 
SEIZURE SUSCEPTIBILITY: INDICATIONS FROM MUTANT MICE 
 
We recently investigated seizure susceptibility in mutant mice with conditional 
inactivation of the Otx2 gene in DA precursor cells. In these mice, Otx2 was 
conditionally inactivated by a Cre recombinase expressed under the transcriptional 
control of the Engrailed1 (En1) gene (En1Cre/+; Otx2flox/flox), resulting in a reduced 
number of DA neurons and an increased number of 5-HT neurons in the ventral 
midbrain that persists until adult age [39, 48]. In particular, adult En1Cre/+; Otx2flox/flox 
mice showed a massive increase of 5-HT in the pons, ventral midbrain, hippocampus 
(CA3 subfield) and cerebral cortex, that was paralleled by reduced levels of 5-HT 
transporter (Sert) in the same areas. Due to this increased 5-HT hyper-innervation, 
En1Cre/+; Otx2flox/flox mice were resistant to generalized seizures induced by the 
glutamate agonist kainic-acid (KA) (Figure 2). Brain 5-HT depletion in mutant mice 







Figure 2. Seizure susceptibility in mutant mice with altered development of DA and 5-HT 
neurons. En1Cre/+;Otx2flox/flox mice show a marked resistance to kainic acid (KA)-induced 
seizures, as compared to their controls (Otx2flox/flox mice). Conversely, no significant difference 
in KA seizure score is detectable between En1+/-; En2-/- (HT) mice and their wild-type (WT) 
controls (C57Bl/6x129Sv mixed genetic background). Otx2flox/flox control mice have a higher KA 
susceptibility respect to WT mice since they are generated in the KA-sensitive DBA2 
background [48]. Bars represent the maximum seizure rating scale value scored by each 
genotype (n = 8-10 animals per group) over a period of two hours after intraperitoneal (i.p.) 
administration of KA (20 mg/kg). Data are expressed as mean ± s.d. ** p<0.001, t-test; n.s., not 
statistically significant difference (p>0.05, t-test). Seizures were scored as described in [48]: 
stage 0: normal behavior; stage 1: immobility; stage 2: forelimb and/or tail extension, rigid 
posture; stage 3: repetitive movements, head bobbing; stage 4: forelimb clonus with rearing and 
falling (limbic motor seizure); stage 5: continuous rearing and falling; stage 6: severe whole 
body convulsions (tonic-clonic seizures); stage 7: death. Data for Otx2flox/flox and 






In parallel experiments, we also evaluated KA seizure susceptibility in En1+/-; En2-/- 
mutant mice (HT mice), which display a post-natal and progressive loss of DA neurons 
of the substantia nigra [49]. It is important to point out that the post-natal DA cell loss 
in HT mice is not accompanied by increased number of 5-HT cells (our unpublished 
observations). HT mice did not show significantly altered seizure susceptibility when 





Altered expression and function of homeobox genes during brain development may 
lead to abnormal specification of brain areas, neuronal identity, circuit formation, 
ultimately leading to an imbalance between excitation and inhibition. Our studies, 
carried out in mutant mouse lines lacking Otx2 or Engrailed1/2 genes, show that altered 
specification of DA and 5-HT cell fate results in altered seizure susceptibility in the 
adult age. Classical pharmacological studies indicate that both DA and 5-HT may have 
an anti-epileptic action. It might be therefore questioned that reduction of DA cells in 
both En1Cre/+; Otx2flox/flox and HT mice could contribute to lower seizure susceptibility 
in these animals. On the contrary, En1Cre/+; Otx2flox/flox mice were markedly resistant to 
KA seizures due to 5-HT hyper-innervation, whereas HT mice (in which 5-HT levels 
were unchanged) showed a normal susceptibility to KA seizures. These results suggest 
that the effect of 5-HT hyper-innervation onto seizure control is more prominent than 






ANR, anterior neural ridge; 
Aadc, aromatic amino-acid decarboxylase; 
CNS, Central Nervous System; 
DA, dopamine; 
Dat, dopamine transporter; 
D2r, dopamine D2 receptor; 
E, embryonic stage; 
En, Engrailed; 
Fgf, fibroblast growth factor; 
FP, foorplate 
Gdnf, glial cell line-derived neurotrophic factor; 
Gdnfrα-1, glial cell-line derived neurotrophic factor receptor α-1; 
HT mice, En1+/-; En2-/- mutant mice; 
5-HT, 5-hydroxytryptamine (serotonin); 
8-OH-DPAT, 8-hydroxy-2-(di-n-propylamino) tetralin; 
KA, kainic acid; 





Sert, serotonin transporter; 
Shh, Sonic hedgehog; 
Th, tyrosine hydroxylase; 
Tph, tryptophan hydroxylase: 
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